Processing 00000000.tx.1: Apolipoprotein E Inhibits Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Migration and Proliferation by Suppressing Signal Transduction and Preventing Cell Entry to G1 Phase* Masato Ishigami, Debi K. 

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C2265920:smooth muscle cell migration [Cell Function]
   821   C2265821:muscle cell migration [Cell Function]
   805   C0302121:Blood cell migration [Cell Function]
   804   C1622501:Migration, Cell [Cell Function]
   790   C0600210:Migration [Social Behavior]
   790   C1533574:Migration [Physiologic Function]
   790   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "Proliferation by Suppressing Signal Transduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0334094:Proliferation [Pathologic Function]
   760   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "Preventing Cell Entry to G1 Phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]

Phrase: "* Masato Ishigami,"

Phrase: "Debi K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: Swertfeger, Norman A. 

Phrase: "Swertfeger,"

Phrase: "Norman A."
Processing 00000000.tx.3: Granholm, and David Y. 

Phrase: "Granholm,"

Phrase: "and"

Phrase: "David Y."
Processing 00000000.tx.4: Hui From the Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0529  ABSTRACT Top Abstract Introduction Procedures Results Discussion References The anti-atherogenic effects of apolipoprotein (apo) E have been attributed to its ability to reduce plasma cholesterol level and to limit foam cell formation. 

Phrase: "Hui From the Department of Pathology"

Phrase: "and"

Phrase: "Laboratory Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Cincinnati College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "Cincinnati,"

Phrase: "Ohio 45267-0529  ABSTRACT Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The anti-atherogenic effects of apolipoprotein (apo) E"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "attributed to its ability to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0085732:Ability [Organism Attribute]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "reduce"

Phrase: "plasma cholesterol level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0201950:cholesterol level [Laboratory Procedure]
   901   C0428466:Cholesterol level [Laboratory or Test Result]
   901   C0858034:plasma cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "foam cell formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0016390:Foam cell [Cell]
Processing 00000000.tx.5: The purpose of this study was to ascertain if apoE also may have cytostatic functions that could attenuate vascular occlusive diseases. 

Phrase: "The purpose of this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0681832:purpose of study [Research Activity]
   760   C1285529:Purpose [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "if"

Phrase: "apoE also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "have"

Phrase: "cytostatic functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "that"

Phrase: "could"

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "vascular occlusive diseases."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   988   C0750145:vascular occlusive disease [Disease or Syndrome]
   913   C0042373:Vascular Diseases [Disease or Syndrome]
   863 E C0018939:Blood Diseases [Disease or Syndrome]
   846 E C1533163:Blood disease [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.6: Purified apoE inhibited smooth muscle cell migration directed to platelet-derived growth factor (PDGF) or oxidized LDL (oxLDL) (p<0.0001). 

Phrase: "Purified apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "smooth muscle cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2265920:smooth muscle cell migration [Cell Function]
   923   C2265821:muscle cell migration [Cell Function]
   861   C1622501:Migration, Cell [Cell Function]
   812   C0600210:Migration [Social Behavior]
   812   C1533574:Migration [Physiologic Function]
   812   C1881827:MIGRATION [Phenomenon or Process]
   756   C1135918:Smooth muscle cell [Cell]

Phrase: "directed to platelet-derived growth factor (PDGF)"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "oxidized LDL (oxLDL) (p<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0030011:oxidize [Molecular Function]

Phrase: ")."
Processing 00000000.tx.7: The purified apoE also suppressed PDGF- and oxLDL-induced smooth muscle cell proliferation (p<0.001). 

Phrase: "The purified apoE also suppressed PDGF-"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   836   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0005821:Platelet [Cell]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0220844:growth [Physiologic Function]
   793   C1441547:Derived [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   793   C3245521:derived [Idea or Concept]
   710 E C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "oxLDL-induced smooth muscle cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C1658578:smooth muscle cell proliferation [Cell Function]
   845   C2246389:muscle cell proliferation [Cell Function]
   818   C0596290:Cell Proliferation [Cell Function]
   795   C0334094:Proliferation [Pathologic Function]
   795   C1514485:Proliferation [Functional Concept]

Phrase: "(p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.8: These apoE inhibitory effects were not because of suppression of PDGF binding to its receptors on the smooth muscle cells, but was correlated with a significant reduction in agonist-stimulated mitogen-activated protein kinase activity (p<0.01). 

Phrase: "These apoE inhibitory effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "not because of suppression of PDGF binding"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   833   C1522950:platelet-derived growth factor binding [Molecular Function]
   806   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1149299:Growth Factor Binding [Molecular Function]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0151686:Growth suppression [Pathologic Function]
   757   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   739   C0005821:Platelet [Cell]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0220844:growth [Physiologic Function]
   739   C0221103:Suppression [Pathologic Function]
   739   C0243122:binding [Functional Concept]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1441547:Derived [Qualitative Concept]
   739   C1518422:Not [Functional Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3245521:derived [Idea or Concept]

Phrase: "to its receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "on the smooth muscle cells,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "but"

Phrase: "was"

Phrase: "correlated with a significant reduction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "in agonist-stimulated mitogen-activated protein kinase activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   913   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   845   C1150527:protein kinase activity [Molecular Function]
   829   C1537044:protein activity [Molecular Function]
   827 E C2261495:protein phosphokinase activity [Molecular Function]
   825   C1752930:mitogenic activity [Cell Function]
   818   C1150423:kinase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   710   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.9: ApoE also inhibited PDGF-induced cyclin D1 mRNA expression, suggesting that the apoE effect was mediated by growth arrest at the G0 to G1 phase. 

Phrase: "ApoE also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-induced cyclin D1 mRNA expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C1515670:mRNA Expression [Genetic Function]
   791   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the apoE effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "mediated by growth arrest"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0333951:Growth arrest [Pathologic Function]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0220844:growth [Physiologic Function]
   770   C0237477:Arrest [Temporal Concept]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "at the G0"

Phrase: "to G1 phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079395:G1 Phase [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.10: Taken together, these results suggest that apoE has cytostatic functions in the vessel wall and may protect against vascular diseases through inhibition of cell signaling events associated with growth factor-induced smooth muscle cell migration and proliferation.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "has"

Phrase: "cytostatic functions in the vessel wall"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "may"

Phrase: "protect against vascular diseases"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0042373:Vascular Diseases [Disease or Syndrome]
   783 E C0018939:Blood Diseases [Disease or Syndrome]
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   766 E C1533163:Blood disease [Disease or Syndrome]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "through inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of cell signaling events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: "associated with growth factor-induced smooth muscle cell migration"
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
   818   C2265920:smooth muscle cell migration [Cell Function]
   790   C1135918:Smooth muscle cell [Cell]
   790   C2265821:muscle cell migration [Cell Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C0596981:Muscle cell [Cell]
   764   C1267092:Muscle, Smooth [Tissue]
   764   C1622501:Migration, Cell [Cell Function]
   762   C0007595:Cell Growth [Cell Function]
   762   C0699040:cell associated [Cell Component]
   742   C0007634:Cell [Cell]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0026845:Muscle [Tissue]
   742   C0205263:Induced [Functional Concept]
   742   C0205357:Smooth [Qualitative Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0600210:Migration [Social Behavior]
   742   C1269647:Cell [Cell]
   742   C1521761:Factor [Functional Concept]
   742   C1533574:Migration [Physiologic Function]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1704653:Cell [Medical Device]
   742   C1881827:MIGRATION [Phenomenon or Process]
   742   C1948049:Cell [Spatial Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.11: INTRODUCTION Top Abstract Introduction Procedures Results Discussion References Research in the past two decades has clearly established that apolipoprotein (apo)1 E protects against vascular diseases (1). 

Phrase: "INTRODUCTION Top Abstract Introduction Procedures Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "Research in the past two decades"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035168:research [Research Activity]
   753   C0205448:Two [Quantitative Concept]
   753   C0242481:Research [Research Activity]
   753   C1444637:Past [Temporal Concept]
   719   C2981279:Decade [Quantitative Concept]

Phrase: "has"

Phrase: "clearly"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that apolipoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(apo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "1 E"

Phrase: "protects against vascular diseases"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0042373:Vascular Diseases [Disease or Syndrome]
   783 E C0018939:Blood Diseases [Disease or Syndrome]
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   766 E C1533163:Blood disease [Disease or Syndrome]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Early studies suggest that the protective effect may be related to the ability of apoE to promote cholesterol efflux from peripheral cells and to mediate the clearance of cholesterol-enriched lipoproteins from circulation (1). 

Phrase: "Early studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the protective effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "related to the ability of apoE to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085732:Ability [Organism Attribute]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cholesterol efflux from peripheral cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C2246761:cholesterol efflux [Cell Function]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the clearance of cholesterol-enriched lipoproteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Transgenic mice overexpressing rat apoE displayed marked resistance to diet-induced hypercholesterolemia and did not develop atherosclerosis (2, 3). 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "rat apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "marked resistance to diet-induced hypercholesterolemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0332325:Resistant to [Functional Concept]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "atherosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: In contrast, mice with targeted disruption of the apoE gene developed spontaneous atherosclerosis even under basal low fat/low cholesterol dietary conditions (4-7). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "mice with targeted disruption of the apoE gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1417166:MICE gene [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "spontaneous atherosclerosis even under basal low fat/low cholesterol dietary conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "(4-7"

Phrase: ")."
Processing 00000000.tx.15: Atherosclerosis in apoE-null mice could be prevented by increasing circulating apoE level through recombinant adenovirus-mediated apoE gene transfer to the liver (8). 

Phrase: "Atherosclerosis in apoE-null mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "could"

Phrase: "be"

Phrase: "prevented by increasing circulating apoE level"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0175630:Circulating [Functional Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0442808:Increasing [Functional Concept]
   753   C0456079:Level [Classification]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
   719   C0309872:PREVENT [Pharmacologic Substance]
   719 E C0442805:Increase [Functional Concept]

Phrase: "through recombinant adenovirus-mediated apoE gene transfer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1412481:APOE gene [Gene or Genome]
   827   C1517499:Gene Transfer [Molecular Biology Research Technique]
   799   C0017337:Gene [Gene or Genome]
   799   C0040671:Transfer [Mental Process]
   799   C1705822:Transfer [Activity]

Phrase: "to the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.16: The decrease in atherosclerosis in this model was accompanied by decreased total cholesterol and VLDL/IDL levels (8). 

Phrase: "The decrease in atherosclerosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "accompanied by decreased total cholesterol"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0201950:Total Cholesterol [Laboratory Procedure]
   806   C0543421:Total cholesterol [Steroid]
   797 E C1442946:Cholesterol.total [Laboratory or Test Result]
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "VLDL/IDL levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.17: The relationship between apoE and cholesterol transport suggests that it prevents atherosclerosis by lowering of plasma cholesterol level. 

Phrase: "The relationship between apoE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "cholesterol transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159709:cholesterol transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "atherosclerosis by lowering of plasma cholesterol level."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004153:Atherosclerosis [Disease or Syndrome]
Processing 00000000.tx.18: However, atherosclerosis was found to be more severe in chow-fed apoE-null mice than in cholesterol-fed apoE(+/+) mice, despite the relative similar plasma cholesterol level in the two groups (7). 

Phrase: "However,"

Phrase: "atherosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more severe in chow-fed apoE-null mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205082:Severe [Qualitative Concept]

Phrase: "than"

Phrase: "in cholesterol-fed apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]

Phrase: "(+/+"

Phrase: ")"

Phrase: "mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "despite the relative similar plasma cholesterol level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0201950:cholesterol level [Laboratory Procedure]
   840   C0428466:Cholesterol level [Laboratory or Test Result]
   840   C0858034:plasma cholesterol [Laboratory Procedure]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]

Phrase: "in the two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.19: Additionally, transgenic expression of apoE in the arterial wall inhibited atheroma formation and severity without affecting plasma cholesterol level and lipoprotein profile in cholesterol-fed C57BL/6 mice (9). 

Phrase: "Additionally,"

Phrase: "transgenic expression of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the arterial wall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0507850:Arterial wall [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "atheroma formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "severity without affecting plasma cholesterol level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439793:Severity [Qualitative Concept]
   753   C2983285:Severity [Intellectual Product]

Phrase: "and"

Phrase: "lipoprotein profile in cholesterol-fed C57BL/6 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.20: Although these two studies characterized atherosclerotic lesions based solely on macrophage foam cell deposition, it is noteworthy that increased number of intimal smooth muscle cells was observed in stenotic lesion area of the external carotid artery (10) and fibroproliferative atherosclerotic plaques of chow-fed apoE-null mice (11). 

Phrase: "Although"

Phrase: "these two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "atherosclerotic lesions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0221198:lesions [Finding]
   861   C0333482:Atherosclerotic [Functional Concept]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "based"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1527178:Based [Functional Concept]
  1000   C1705938:Based [Idea or Concept]
   966 E C0002055:base [Inorganic Chemical]
   966 E C0178499:Base [Chemical Viewed Functionally]
   966 E C1880279:Base [Biomedical or Dental Material]

Phrase: "solely on macrophage foam cell deposition,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0016390:Foam cell [Cell]
           Foamy Macrophage
   753   C0007634:Cell [Cell]
   753   C0024432:macrophage [Cell]
   753   C0280592:FOAM [Therapeutic or Preventive Procedure]
   753   C0333562:Deposition [Functional Concept]
   753   C0991510:Foam [Biomedical or Dental Material]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that increased number of intimal smooth muscle cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "observed in stenotic lesion area of the external carotid artery"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   782   C0007275:Carotid Artery, External [Body Part, Organ, or Organ Component]
   764   C0751636:External Carotid Artery Stenosis [Disease or Syndrome]
   760   C0007272:Carotid artery [Body Part, Organ, or Organ Component]
   760   C0162859:Carotid artery [Body Part, Organ, or Organ Component]
   751   C0007282:artery carotid stenosis [Disease or Syndrome]
           Carotid Stenosis
   751   C0038449:Stenosis of artery [Disease or Syndrome]
           artery stenosis
   739   C0003842:Artery [Body Part, Organ, or Organ Component]
   739   C0017446:Area [Geographic Area]
   739   C0205101:External [Spatial Concept]
   739   C0205146:Area [Spatial Concept]
   739   C0221198:Lesion [Finding]
   739   C0226004:artery [Body System]
   739   C0333181:Stenotic [Functional Concept]
   739   C0741968:Carotid [Body Part, Organ, or Organ Component]
   739   C1441672:Observed [Functional Concept]
   739   C1546698:Lesion [Intellectual Product]

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "fibroproliferative atherosclerotic plaques of chow-fed apoE-null mice"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C2936350:Atherosclerotic Plaques [Body Substance]
   742   C0333463:plaques [Acquired Abnormality]
   742   C0333482:Atherosclerotic [Functional Concept]
   708 E C0011389:Plaque [Disease or Syndrome]
   708 E C0332461:Plaque [Finding]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.21: Taken together, these results suggest that apoE may have direct impact on vascular occlusive diseases in a manner in addition to, and independent of, its property as a cholesterol-transporting apolipoprotein. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "have"

Phrase: "direct impact on vascular occlusive diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "in a manner"

Phrase: "in addition to,"

Phrase: "and independent of,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0332291:Independent of [Functional Concept]
   790   C0085862:Independent [Idea or Concept]
   790   C1299583:Independent [Finding]
   790   C1515981:And [Idea or Concept]

Phrase: "its property as a cholesterol-transporting apolipoprotein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0871161:Property [Qualitative Concept]
   748   C1882134:Property [Conceptual Entity]
   748   C2347695:Property [Entity]
Processing 00000000.tx.22: Recently, apoE gene polymorphism has been shown to correlate with risk of restenosis after balloon angioplasty (12). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "apoE gene polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0678951:gene polymorphism [Genetic Function]
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C1412481:APOE gene [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with risk of restenosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035647:Risk [Qualitative Concept]
   760   C0333186:Restenosis [Acquired Abnormality]

Phrase: "after balloon angioplasty"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0002996:Angioplasty, Balloon [Therapeutic or Preventive Procedure]
  1000   C0002997:balloon angioplasty [Therapeutic or Preventive Procedure]
   861   C0162577:Angioplasty [Therapeutic or Preventive Procedure]
   861   C0336867:Balloon [Manufactured Object]
   861   C0441144:balloon [Medical Device]
   861   C1548817:Angioplasty [Health Care Activity]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.23: Because lipid deposition and foam cell formation is a late event in restenosis, this correlation adds support to the hypothesis that apoE may have cell regulatory functions in the vessel wall. 

Phrase: "Because"

Phrase: "lipid deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333574:Lipid deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "foam cell formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0016390:Foam cell [Cell]

Phrase: "is"

Phrase: "a late event in restenosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441471:Event [Event]

Phrase: "this correlation adds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883712:Add [Functional Concept]

Phrase: "support to the hypothesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0183683:Support [Medical Device]
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1521721:Support [Conceptual Entity]

Phrase: "that apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "have"

Phrase: "cell regulatory functions in the vessel wall."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   774   C0007613:cell functions [Cell Function]
   748   C0542341:Functions [Functional Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.24: A prominent vascular abnormality observed in both spontaneous atherosclerosis and restenosis after angioplasty is the migration of vascular smooth muscle cells from the medial layer of the blood vessel to its intima, followed by proliferation of the intimal smooth muscle cells. 

Phrase: "A prominent vascular abnormality"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0241657:VASCULAR ABNORMALITY [Finding]
   837 E C0741583:blood vessel abnormal [Finding]
   827   C1704258:Abnormality [Finding]
   755 E C0205161:Abnormal [Qualitative Concept]
   755 E C2347472:% Abnormal [Quantitative Concept]
   755 E C2699333:ABNORMAL [Intellectual Product]
   706   C0425660:Prominent blood vessel [Finding]

Phrase: "observed in both spontaneous atherosclerosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0004153:Atherosclerosis [Disease or Syndrome]
   760   C0205359:Spontaneous [Functional Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "restenosis after angioplasty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333186:Restenosis [Acquired Abnormality]

Phrase: "is"

Phrase: "the migration of vascular smooth muscle cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   823   C2265920:smooth muscle cell migration [Cell Function]
   788   C2265821:muscle cell migration [Cell Function]
   774   C1622501:cells migration [Cell Function]
   756   C0302121:Blood cell migration [Cell Function]
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from the medial layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "of the blood vessel"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
  1000   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   944 E C1558950:VASCULAR [Finding]
   944 E C1801960:Vascular [Qualitative Concept]
   916 E C0005767:Blood [Tissue]
   916 E C0005768:blood [Body Substance]
   916 E C0229664:Blood [Body Substance]
   916 E C0392895:Bloods [Population Group]
   893 E C0333275:Bloody [Qualitative Concept]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "to its intima,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162864:Intima [Tissue]
  1000   C1256463:Intima [Tissue]

Phrase: "followed by proliferation of the intimal smooth muscle cells."
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   793   C1658578:smooth muscle cell proliferation [Cell Function]
   790   C1135918:Smooth Muscle Cells [Cell]
   767   C2246389:muscle cell proliferation [Cell Function]
   764   C0332283:Followed by [Temporal Concept]
           followed
   764   C0596981:Muscle Cells [Cell]
   764   C1267092:Muscle, Smooth [Tissue]
   762   C0334096:Intimal proliferation [Pathologic Function]
   745   C0596290:Cell Proliferation [Cell Function]
   742   C0007634:Cells [Cell]
   742   C0026845:Muscle [Tissue]
   742   C0205357:Smooth [Qualitative Concept]
   742   C0334094:Proliferation [Pathologic Function]
   742   C1514485:Proliferation [Functional Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1719822:Follow [Intellectual Product]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.25: These processes are regulated by growth factors released from cells within the injured artery or from circulating cells in plasma. 

Phrase: "These processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "are"

Phrase: "regulated by growth factors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "released from cells"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "within the injured artery"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0003842:Artery [Body Part, Organ, or Organ Component]
   861   C0226004:artery [Body System]
   789 E C0221464:Arterial [Spatial Concept]

Phrase: "or from circulating cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0175630:Circulating [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in plasma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.26: Potent mitogens and chemoattractants that participate in vascular disease include PDGF and oxLDL. 

Phrase: "Potent mitogens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026249:Mitogens [Pharmacologic Substance]
   827 E C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "chemoattractants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008013:Chemoattractants [Biologically Active Substance]

Phrase: "that"

Phrase: "participate in vascular disease"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   833   C0042373:Vascular disease [Disease or Syndrome]
   783 E C0018939:Blood disease NOS [Disease or Syndrome]
   783 E C1533163:Blood disease [Disease or Syndrome]
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "oxLDL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.27: These reagents direct migration of vascular smooth muscle cells from the media to the intima of the vessel and induce proliferation of the intimal smooth muscle cells (13, 14). 

Phrase: "These reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "migration of vascular smooth muscle cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   847   C2265920:smooth muscle cell migration [Cell Function]
   804   C2265821:muscle cell migration [Cell Function]
   783   C1622501:cells migration [Cell Function]
   770   C0302121:Blood cell migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "to the intima"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162864:Intima [Tissue]
  1000   C1256463:Intima [Tissue]

Phrase: "of the vessel"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005847:Vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:Vessel [Tissue]
   944 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "proliferation of the intimal smooth muscle cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C1658578:smooth muscle cell proliferation [Cell Function]
   788   C2246389:muscle cell proliferation [Cell Function]
   774   C0334096:Intimal proliferation [Pathologic Function]
   757   C0596290:Cell Proliferation [Cell Function]
   748   C0334094:Proliferation [Pathologic Function]
   748   C1514485:Proliferation [Functional Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.28: The mechanism of cell activation is reported to be mediated via the activation of mitogen-activated protein (MAP) kinase (15). 

Phrase: "The mechanism of cell activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mediated via the activation of mitogen-activated protein (MAP) kinase"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   784   C1819041:protein kinase activation [Cell Function]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0599177:protein activation [Genetic Function]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C1879547:Activated [Activity]
           Activation
   708 E C1515877:Activate [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.29: Because apoE has been shown to inhibit mitogen-stimulated lymphocyte proliferation through suppression of early cell signaling events (16), the current study is undertaken to explore the possibility that apoE may protect against vascular diseases by inhibiting vascular smooth muscle cell migration and proliferation.  

Phrase: "Because"

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mitogen-stimulated lymphocyte proliferation through suppression of early cell signaling events"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0596873:lymphocyte proliferation [Cell Function]
   754   C0596290:Cell Proliferation [Cell Function]
   754   C1518065:Lymphocyte Suppression [Cell Function]
   738   C0024264:Lymphocyte [Cell]
   738   C0334094:Proliferation [Pathologic Function]
   738   C1514485:Proliferation [Functional Concept]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "undertaken"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the possibility"

Phrase: "that apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "protect against vascular diseases"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0042373:Vascular Diseases [Disease or Syndrome]
   783 E C0018939:Blood Diseases [Disease or Syndrome]
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   766 E C1533163:Blood disease [Disease or Syndrome]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "by inhibiting vascular smooth muscle cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C2265920:smooth muscle cell migration [Cell Function]
   861   C2265821:muscle cell migration [Cell Function]
   852   C0302121:Blood cell migration [Cell Function]
   827   C1622501:Migration, Cell [Cell Function]
   799   C0600210:Migration [Social Behavior]
   799   C1533574:Migration [Physiologic Function]
   799   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.30: EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion References Materials-- Human recombinant PDGF-BB, FBS, and Dulbecco's modified Eagle's medium (DMEM) were purchased from Life Technologies, Inc. 

Phrase: "EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "Human recombinant PDGF-BB,"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   954   C0140908:platelet-derived growth factor BB, recombinant [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C1515387:Recombinant Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   911   C1299006:Human platelet-derived growth factor [Pharmacologic Substance]
   911   C3537235:Human Platelet-derived Growth Factor [Pharmacologic Substance]
   877   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   868   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   845   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0004739:BB [Geographic Area]
   795   C0005821:Platelet [Cell]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C0332297:BB [Spatial Concept]
   795   C1441547:Derived [Qualitative Concept]
   795   C1514798:recombinant [Organism]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   795   C3245521:derived [Idea or Concept]
   712 E C1963076:Platelets [Finding]

Phrase: "FBS,"

Phrase: "and"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "(DMEM"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Life Technologies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.31: (Gaithersburg, MD). 

Phrase: "(Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.32: [Methyl-3H]thymidine, [(-32P]ATP, [-32P]dCTP, and 125I-PDGF-BB were obtained from NEN Life Science Products. 

Phrase: "[Methyl-3H]thymidine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1442460:3H [Temporal Concept]

Phrase: "["

Phrase: "(-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP,"

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "125I-PDGF-BB"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   947   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0004739:BB [Geographic Area]
   799   C0005821:Platelet [Cell]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0332297:BB [Spatial Concept]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3245521:derived [Idea or Concept]
   716 E C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "obtained from NEN Life Science Products."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332070:Life Science Products [Health Care Related Organization]
   790   C0005526:Science, Life [Occupation or Discipline]
   753   C0036397:Science [Occupation or Discipline]
   753   C0376558:Life [Idea or Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.33: Activated MAP kinase, insulin-regulated phosphorylated heat- and acid-stable protein (PHAS-I), the MAP kinase assay kit, and QuikhybTM hybridization solution were products of Stratagene (La Jolla, CA). 

Phrase: "Activated MAP kinase,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "phosphorylated heat-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "acid-stable protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PHAS-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0254260:PHAS-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414352:PHAS-I [Gene or Genome]
  1000   C2984182:PHAS-I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "the MAP kinase assay kit,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0812225:KIT [Medical Device]
   799   C1150635:KIT [Molecular Function]
   799   C1705212:Kit [Medical Device]
   799   C1705213:KIT [Medical Device]
   799   C3273202:Kit [Manufactured Object]
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "QuikhybTM hybridization solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "products of Stratagene"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1514468:Products [Entity]
   756 E C1704444:Product [Quantitative Concept]

Phrase: "(La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)."
Processing 00000000.tx.34: The Cell Titer 96TM AQueous cell proliferation assay kit was purchased from Promega, Inc. 

Phrase: "The Cell Titer 96TM AQueous cell proliferation assay kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0812225:KIT [Medical Device]
   793   C1150635:KIT [Molecular Function]
   793   C1705212:Kit [Medical Device]
   793   C1705213:KIT [Medical Device]
   793   C3273202:Kit [Manufactured Object]

Phrase: "was"

Phrase: "purchased from Promega,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0072149:Promega [Lipid]
   790   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.35: (Madison, WI). 

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.36: The embryonic rat aortic smooth muscle-derived A7r5 cells were obtained from American Type Culture Collection (Manassas, VA). 

Phrase: "The embryonic rat aortic smooth muscle-derived A7r5 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   894   C0596995:Muscle Cells, Embryonic [Cell]
   875   C1947950:Embryonic Cell [Embryonic Structure]
   855   C1135918:Smooth Muscle Cells [Cell]
   836   C0596981:Muscle Cells [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "obtained from American Type Culture Collection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C1301820:Obtained [Functional Concept]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "(Manassas,"

Phrase: "VA)."
Processing 00000000.tx.37: Human coronary artery smooth muscle cells were purchased from Clonetics (San Diego, CA). 

Phrase: "Human coronary artery smooth muscle cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   895   C0427861:Human cells [Laboratory or Test Result]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "purchased from Clonetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.38: Transwell chambers with gelatin-treated polycarbonate membranes were obtained from Corning Coster Corp. 

Phrase: "Transwell chambers with gelatin-treated polycarbonate membranes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0179874:chambers [Medical Device]
   714 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "obtained from Corning Coster Corp."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0010046:corning [Acquired Abnormality]
   760   C0683758:Corp. [Organization]
   760   C1301820:Obtained [Functional Concept]
   726 E C0010028:Corn [Plant]
   726 E C0087179:Corn [Plant]
   726 E C1095906:corn [Pharmacologic Substance]
   726 E C1138842:Corn [Food]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.39: (Cambridge, MA). 

Phrase: "(Cambridge,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.40: Cell Culture-- The A7r5 cells were grown in monolayer cultures on plastic tissue culture-treated multiple well cluster plates in DMEM containing 10% FBS, 100units/ml penicillin, 0.1mg/ml streptomycin, and 2mM glutamine. 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "The A7r5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in monolayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0872351:monolayer [Clinical Drug]

Phrase: "cultures on plastic tissue culture-treated multiple well"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   770   C0040284:Tissue culture [Laboratory Procedure]
           culture tissue
   744   C0010453:Culture [Idea or Concept]
   744   C0032167:Plastic [Substance]
   744   C0040300:Tissue [Tissue]
   744   C0205170:Well [Qualitative Concept]
   744   C0220814:culture [Functional Concept]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0439064:Multiple [Quantitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1547928:Tissue [Intellectual Product]
   744   C2242979:Culture [Laboratory Procedure]
   744   C3146287:Well [Manufactured Object]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "cluster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555715:Cluster [Idea or Concept]
  1000   C1704332:Cluster [Quantitative Concept]

Phrase: "plates in DMEM"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1139930:plates [Medical Device]
   756 E C0005971:Plate [Medical Device]
   756 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% FBS,"

Phrase: "100units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "0.1mg/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "2mM glutamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.41: Cells were incubated at 37C in 95% air, 5% CO2 atmosphere and were used for experiments between passages 3-12. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 95% air,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0001861:Air [Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "5% CO2 atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004178:Atmosphere [Natural Phenomenon or Process]
   827   C0678214:atmosphere [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "used for experiments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "between passages 3-12."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0439799:Passage [Spatial Concept]
Processing 00000000.tx.42: Human coronary artery smooth muscle cells were grown in smooth muscle cell growth medium provided by the supplier. 

Phrase: "Human coronary artery smooth muscle cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   895   C0427861:Human cells [Laboratory or Test Result]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "grown in smooth muscle cell growth medium"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   814   C1135918:Smooth muscle cell [Cell]
   778   C0007595:Cell Growth [Cell Function]
   778   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   778   C0596981:Muscle cell [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0007634:Cell [Cell]
   748   C0009458:Medium [Intellectual Product]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0026845:Muscle [Tissue]
   748   C0205357:Smooth [Qualitative Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0439536:Medium [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1704653:Cell [Medical Device]
   748   C1705217:Medium [Substance]
   748   C1948049:Cell [Spatial Concept]
   748   C2911660:Growth [Activity]
   748   C3244283:medium [Intellectual Product]

Phrase: "provided by the supplier."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0470689:Supplier [Health Care Related Organization]
   770   C0470690:supplier [Health Care Related Organization]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.43: Cells were used for experiments between passages 5and 8.In all experiments, the cells were made quiescent by incubating for 48h in the presence of 0.4% FBS prior to use. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used for experiments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "between passages 5and 8."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0439799:Passage [Spatial Concept]

Phrase: "In all experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "quiescent by incubating"

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.4% FBS"

Phrase: "prior to use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.44: Preparation of Apolipoproteins and Lipoproteins-- Human apoE was isolated from fresh plasma obtained from normal healthy volunteers as detailed by Rall et al. 

Phrase: "Preparation of Apolipoproteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0455052:Preparation [Health Care Activity]
   790   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "Human apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "isolated from fresh plasma"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0032105:Plasma [Body Substance]
   770   C0205409:Isolated [Functional Concept]
   770   C0443224:Fresh [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C2827486:Fresh [Body Substance]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "obtained from normal healthy volunteers"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C1708335:Healthy Volunteers [Population Group]
   797   C3661466:Normal Volunteers [Population Group]
   760   C0042960:Volunteers [Professional or Occupational Group]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C2347086:% Normal [Quantitative Concept]
   726 E C1549078:Volunteer [Idea or Concept]
   726 E C1706701:Obtain [Activity]
   726 E C1997894:volunteer [Population Group]

Phrase: "as"

Phrase: "detailed by Rall et al."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1522508:Detailed [Qualitative Concept]
   726 E C1561567:detail [Functional Concept]
Processing 00000000.tx.45: (17). 

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.46: The purity of the apoE preparation was verified based on a single band with Mr=34,000in SDS-polyacrylamide gels. 

Phrase: "The purity of the apoE preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882508:Purity [Quantitative Concept]

Phrase: "was"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "based on a single band"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0175723:Band [Medical Device]
   760   C0205171:Single [Quantitative Concept]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "with Mr=34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "000in SDS-polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gels [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   779 E C1382104:Gel [Substance]
Processing 00000000.tx.47: Human LDL (d=1.019-1.063 gm/ml) was isolated by sequential ultracentrifugation and was stored in saline-EDTA solution (18). 

Phrase: "Human LDL ("

Phrase: "d="

Phrase: "1.019-1.063 gm/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "isolated by sequential ultracentrifugation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0041609:Ultracentrifugation [Laboratory Procedure]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "was"

Phrase: "stored in saline-EDTA solution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0036082:Saline Solution [Substance]
           Saline
   760   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   726   C1698986:Store [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.48: Oxidative modification was undertaken by dialyzing the LDL against saline without EDTA and then incubating the lipoproteins with 5mol/L copper sulfate for 48h at 37C. 

Phrase: "Oxidative modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "was"

Phrase: "undertaken by dialyzing"

Phrase: "the LDL against saline"

Phrase: "without EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "the lipoproteins with 5mol/L copper sulfate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.49: The oxidative modification was confirmed by 37C electrophoretic mobility on agarose gels. 

Phrase: "The oxidative modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed by 37C electrophoretic mobility"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "on agarose gels."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1706746:Agarose Gel [Research Device]
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]
Processing 00000000.tx.50: Smooth Muscle Cell Migration Assay-- The migration of smooth muscle cells was examined according to the procedure described by Law et al. 

Phrase: "Smooth Muscle Cell Migration Assay"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   937   C2265920:smooth muscle cell migration [Cell Function]
   884   C1513300:Cell Migration Assay [Laboratory Procedure]
           Migration Assay
   884   C2265821:muscle cell migration [Cell Function]
   840   C1622501:Migration, Cell [Cell Function]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C0600210:Migration [Social Behavior]
   804   C1510438:Assay [Laboratory Procedure]
   804   C1533574:Migration [Physiologic Function]
   804   C1881827:MIGRATION [Phenomenon or Process]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "-"

Phrase: "-"

Phrase: "The migration of smooth muscle cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   847   C2265920:smooth muscle cell migration [Cell Function]
   804   C2265821:muscle cell migration [Cell Function]
   783   C1622501:cells migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "examined according to the procedure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0332128:Examined [Finding]
   760   C0680240:according [Social Behavior]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "by Law et al."
Processing 00000000.tx.51: (19). 

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.52: Briefly, the cells were suspended in DMEM with 0.4% FBS at a concentration of 2105 cells/ml. 

Phrase: "Briefly,"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "suspended in DMEM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553389:suspended [Idea or Concept]
   790   C1553403:suspended [Idea or Concept]
   790   C1705537:Suspended [Functional Concept]

Phrase: "with 0.4% FBS"

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 2105 cells/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2699156:Cells/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.53: The cells were preincubated with 0,25,or 50g/ml apoE for 30min at 37C, and 0.1-ml aliquots of the cell suspension (2104 cells) were added to the top chamber of gelatin-treated Transwell polycarbonate membrane with 8-m pores in 24-well plates. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with 0,"

Phrase: "25,"

Phrase: "or"

Phrase: "50g/ml apoE for 30min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]

Phrase: "at 37C,"

Phrase: "and"

Phrase: "0.1-ml aliquots of the cell suspension"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1510844:Aliquot [Quantitative Concept]

Phrase: "(2104 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "added to the top chamber of gelatin-treated Transwell polycarbonate membrane"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   738   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   738   C0025255:Membrane [Tissue]
   738   C0071524:polycarbonate [Biomedical or Dental Material,Organic Chemical]
   738   C0175905:Polycarbonate [Organic Chemical]
   738   C0332293:treated [Therapeutic or Preventive Procedure]
   738   C0596901:Membrane [Cell Component]
   738   C0935616:Chamber [Body Part, Organ, or Organ Component]
   738   C1145617:Gelatin [Food]
   738   C1522326:Treated [Functional Concept]
   738   C1524062:Added [Functional Concept]
   738   C1704458:Top [Spatial Concept]
   738   C1706182:Membrane [Manufactured Object]
   704 E C1292734:TREAT [Functional Concept]
   704 E C1883712:Add [Functional Concept]

Phrase: "with 8-m pores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1325742:Pore [Cell Component]

Phrase: "in 24-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.54: The lower Transwell compartment contained 0.6ml of DMEM, 0.4% FBS, with or without PDGF-BB or oxLDL. 

Phrase: "The lower Transwell compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "0.6ml of DMEM,"

Phrase: "0.4% FBS,"

Phrase: "with"

Phrase: "or without PDGF-BB"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   853   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   748   C0004739:BB [Geographic Area]
   748   C0005821:Platelet [Cell]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0332297:BB [Spatial Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   748   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "oxLDL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.55: Incubation was continued for 4h at 37C, after which the adherent cells were washed extensively, fixed with methanol, and then stained with hematoxylin. 

Phrase: "Incubation"

Phrase: "was"

Phrase: "continued for 4h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549178:Continued [Idea or Concept]
   790   C1292426:4H [Temporal Concept]

Phrase: "at 37C,"

Phrase: "after"

Phrase: "which the adherent cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0007634:Cells [Cell]
   861   C0334154:Adherent [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively,"

Phrase: "fixed with methanol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained with hematoxylin."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.56: The number of cells that migrated to the lower surface of each filter was counted in different high power fields (HPFs) at a magnification of 320. 

Phrase: "The number of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "migrated to the lower surface of each filter"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0180860:Filter [Manufactured Object]
   744   C0205148:Surface [Spatial Concept]
   744   C0232902:Migrated [Functional Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C0581406:Filter [Medical Device]
   744   C1522664:Filter [Intellectual Product]
   744   C1548802:Lower [Body Location or Region]
   744   C1704449:Filter [Conceptual Entity]
   744   C1704684:Filter [Medical Device]
   744   C1875155:FILTER [Medical Device]
   744   C2003888:Lower [Activity]

Phrase: "was"

Phrase: "counted in different high power fields (HPFs)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   799   C1552990:High Power Field [Quantitative Concept]
   753   C0032863:Power [Human-caused Phenomenon or Process]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C0750480:Count [Activity]
   719   C1521738:Field [Conceptual Entity]
   719   C1705566:Count [Quantitative Concept]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "at a magnification"

Phrase: "of 320."
Processing 00000000.tx.57: [Methyl-3H]Thymidine Incorporation into Cellular DNA-- Cells were plated at a cell density of 5103 cells/well in 96-well tissue culture dishes and then incubated for 48h in DMEM with 0.4% FBS to synchronize cells at the quiescent state. 

Phrase: "[Methyl-3H]Thymidine Incorporation into Cellular DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at a cell density of 5103 cells/well"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C0162339:Cell Density [Quantitative Concept]
   764   C2347578:Cells/well [Quantitative Concept]
   745   C1166718:cell plate [Cell Component]
           cells plate
   742   C0007634:Cell [Cell]
           Cells
   742   C0178587:density [Quantitative Concept]
   742   C0205170:Well [Qualitative Concept]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3146287:Well [Manufactured Object]
   742   C3282337:Cells [Cell]
   708   C0005971:Plate [Medical Device]
   708   C1139930:plate [Medical Device]
   708   C3537155:Plate [Manufactured Object]

Phrase: "in 96-well tissue culture dishes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0492792:DISH, TISSUE CULTURE [Medical Device]
   771   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 48h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442464:48H [Temporal Concept]

Phrase: "in DMEM"

Phrase: "with 0.4% FBS to"

Phrase: "synchronize"

Phrase: "cells at the quiescent state."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.58: The cells were incubated for 20h with PDGF-BB or oxLDL in the presence or absence of apoE. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 20h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with PDGF-BB"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "or"

Phrase: "oxLDL in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0030011:oxidize [Molecular Function]

Phrase: "or"

Phrase: "absence of apoE."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.59: One Ci of [methyl-3H]thymidine was added to the culture medium and the incubation was continued for 4h at 37C. 

Phrase: "One Ci of [methyl-3H]thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1442460:3H [Temporal Concept]

Phrase: "was"

Phrase: "added to the culture medium"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the incubation"

Phrase: "was"

Phrase: "continued for 4h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549178:Continued [Idea or Concept]
   790   C1292426:4H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.60: Cells were washed twice with phosphate-buffered saline followed by incubation at 4C in 25% trichloroacetic acid for 20min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in 25% trichloroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "for 20min."
Processing 00000000.tx.61: The plates were washed three times with cold 25% trichloroacetic acid followed by the addition of 0.25N NaOH. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with cold 25% trichloroacetic acid"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "followed by the addition of 0.25N NaOH."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C1883712:Addition [Functional Concept]
   711 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.62: Radioactivity in the cell lysate was quantitated by liquid scintillation counting. 

Phrase: "Radioactivity in the cell lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "quantitated by liquid scintillation counting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.63: Cell Proliferation Assay-- Smooth muscle cell proliferation was also assessed based on the ability of the cells to convert MTS into formazan, using the AQueous Cell Proliferation Assay Kit. 

Phrase: "Cell Proliferation Assay"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0243073:assay [Qualitative Concept]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1269647:Cell [Cell]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1514485:Proliferation [Functional Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "Smooth muscle cell proliferation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1658578:smooth muscle cell proliferation [Cell Function]
   923   C2246389:muscle cell proliferation [Cell Function]
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]
   756   C1135918:Smooth muscle cell [Cell]

Phrase: "was"

Phrase: "also"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "based on the ability of the cells to"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   744   C0007634:Cells [Cell]
   744   C0085732:Ability [Organism Attribute]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C3282337:Cells [Cell]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "convert"

Phrase: "MTS into formazan,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AQueous Cell Proliferation Assay Kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0812225:KIT [Medical Device]
   804   C1150635:KIT [Molecular Function]
   804   C1705212:Kit [Medical Device]
   804   C1705213:KIT [Medical Device]
   804   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.64: In these experiments, 5 103 quiescent A7r5 or human coronary artery smooth muscle cells in 96-well tissue culture dishes were incubated for 24h with or without PDGF-BB or oxLDL and in the presence or absence of apoE prior to the addition of 20l of MTS mixed with the electron-coupling reagent phenazine methosulfate. 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "5 103 quiescent A7r5"

Phrase: "or"

Phrase: "human coronary artery smooth muscle cells in 96-well tissue culture dishes"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   785   C1706851:Artery Smooth Muscle Tissue [Tissue]
   771   C1135918:Smooth muscle tissue cell [Cell]
           Smooth Muscle Cells
   767   C1267092:Smooth muscle (tissue) [Tissue]
           Muscle, Smooth
   755   C1331092:tissue/cell culture [Laboratory Procedure]
   753   C0596981:Muscle Cells [Cell]
   751   C0007585:cells culture [Laboratory Procedure]
   751   C0026845:Muscle tissue [Tissue]
           Muscle
   751 E C0040284:cell tissue culture [Laboratory Procedure]
   751   C0427861:Human cells [Laboratory or Test Result]
   751   C2328219:Muscle tissue [Tissue]
   751   C2347578:Cells/well [Quantitative Concept]
   736   C0007634:Cells [Cell]
   736   C0205357:Smooth [Qualitative Concept]
   736   C3282337:Cells [Cell]
   734   C2347576:Cells/dish [Quantitative Concept]
   715   C0226002:Muscular artery [Body Part, Organ, or Organ Component]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "with"

Phrase: "or without PDGF-BB"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   853   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   748   C0004739:BB [Geographic Area]
   748   C0005821:Platelet [Cell]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0332297:BB [Spatial Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   748   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "oxLDL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030011:oxidize [Molecular Function]

Phrase: "and in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1515981:And [Idea or Concept]

Phrase: "or"

Phrase: "absence of apoE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 20l"

Phrase: "of MTS"

Phrase: "mixed with the electron-coupling reagent phenazine methosulfate."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0025809:Phenazine Methosulfate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0013852:Electron [Quantitative Concept]
   744   C0031375:phenazine [Organic Chemical]
   744   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   744   C0205430:Mixed [Functional Concept]
   744   C1948027:Coupling [Functional Concept]
   744   C2917605:Phenazine [Organic Chemical,Pharmacologic Substance]
   744   C3160715:Mixed [Finding]
   744   C3463986:Electron [Bird]
   711 E C0010222:couple [Family Group]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.65: Incubation was continued for 1 h at 37C. 

Phrase: "Incubation"

Phrase: "was"

Phrase: "continued for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0549178:Continued [Idea or Concept]
   770   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.66: Formazan formation was measured based on increased absorbance at 490nm. 

Phrase: "Formazan formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "based on increased absorbance"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1268822:Absorbance [Clinical Attribute]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2825050:Absorbance [Phenomenon or Process]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "at 490nm."
Processing 00000000.tx.67: Binding of PDGF to Rat Aortic Smooth Muscle Cells-- Quiescent A7r5 cells plated in 24-well tissue culture dishes were pre-incubated for 3h at 4C with Hanks' balanced salt solution containing 0.2% bovine serum albumin, with or without addition of 25or 50g/ml apoE or 200ng/ml PDGF-BB. 

Phrase: "Binding of PDGF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1522950:platelet-derived growth factor binding [Molecular Function]
   820   C1149299:Growth Factor Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   716   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to Rat Aortic Smooth Muscle Cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   804   C0003483:Aortic [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "--"

Phrase: "Quiescent A7r5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "plated in 24-well tissue culture dishes"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   797   C0492792:DISH, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   757   C0180454:Culture plate [Medical Device]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]
   714   C0005971:Plate [Medical Device]
   714   C0020498:DISH [Disease or Syndrome]
   714   C1139930:plate [Medical Device]
   714   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "pre-incubated for 3h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332152:Pre [Temporal Concept]
   770   C0740175:Pre [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1442460:3H [Temporal Concept]
   770   C2257086:PRE [Genetic Function]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with Hanks' balanced salt solution"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   923   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0206136:Salt [Food,Inorganic Chemical]
   812   C0525069:Solution [Biomedical or Dental Material]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.2% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "with"

Phrase: "or without addition of 25or 50g/ml apoE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439526:/mL [Quantitative Concept]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1412481:APOE [Gene or Genome]
   744   C1883712:Addition [Functional Concept]

Phrase: "or"

Phrase: "200ng/ml PDGF-BB."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   913   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   877   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0004739:BB [Geographic Area]
   795   C0005821:Platelet [Cell]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C0332297:BB [Spatial Concept]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   795   C3245521:derived [Idea or Concept]
   712 E C1963076:Platelets [Finding]
Processing 00000000.tx.68: At the end of this incubation period, 120pmol/liter of 125I-PDGF-BB was added to each well, and incubation was continued for 3h at 4C. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of this incubation period,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:Incubation period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "120pmol/liter of 125I-PDGF-BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0475211:liter [Quantitative Concept]
   720   C0456525:platelets/liter [Quantitative Concept]

Phrase: "was"

Phrase: "added to each well,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubation"

Phrase: "was"

Phrase: "continued for 3h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549178:Continued [Idea or Concept]
   790   C1442460:3H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.69: The cells were washed three times with cold Hanks' solution and then solubilized with 1ml of solution containing 1% Triton X-100 and 0.1% bovine serum albumin. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with cold Hanks' solution"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "solubilized with 1ml of solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "0.1% bovine serum albumin."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
Processing 00000000.tx.70: The radioactivity associated with the cell lysate was quantitated in a gamma counter. 

Phrase: "The radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "associated with the cell lysate"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1881488:Cell Lysate [Physical Object]
           Lysate
   797   C0699040:cell associated [Cell Component]
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "quantitated in a gamma counter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017011:Gamma [Natural Phenomenon or Process]
   760   C0677601:Counter [Manufactured Object]
   760   C1552644:Gamma [Intellectual Product]
   760   C1705206:Counter [Medical Device]
   760   C2349976:Gamma [Quantitative Concept]
Processing 00000000.tx.71: Specific binding was determined as the total amount of 125I-PDGF-BB bound to the cells minus the nonspecific binding observed in the presence of excess unlabeled PDGF-BB. 

Phrase: "Specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "determined as the total amount"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1265611:Amount [Quantitative Concept]

Phrase: "of 125I-PDGF-BB"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   947   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0004739:BB [Geographic Area]
   799   C0005821:Platelet [Cell]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0332297:BB [Spatial Concept]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   799   C3245521:derived [Idea or Concept]
   716 E C1963076:Platelets [Finding]

Phrase: "bound to the cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0699040:cell bound [Cell Component]
   770   C0007634:Cells [Cell]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "observed in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1441672:Observed [Functional Concept]

Phrase: "of excess unlabeled PDGF-BB."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   913   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   877   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0004739:BB [Geographic Area]
   795   C0005821:Platelet [Cell]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C0332297:BB [Spatial Concept]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   795   C3245521:derived [Idea or Concept]
   712 E C1963076:Platelets [Finding]
Processing 00000000.tx.72: Determination of Cyclin D1 mRNA Level in Rat Aortic Smooth Muscle Cells-- A cDNA probe for rat cyclin D1 was prepared by reverse transcription-polymerase chain reaction amplification of mRNA isolated from proliferating cells. 

Phrase: "Determination of Cyclin D1 mRNA Level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "in Rat Aortic Smooth Muscle Cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   804   C0003483:Aortic [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "A cDNA probe for rat cyclin D1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0182400:Probe [Medical Device]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "prepared by reverse transcription-polymerase chain reaction amplification of mRNA"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   833   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0035380:Reverse Transcription [Genetic Function]
   757   C1158816:mRNA transcription [Genetic Function]
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0040649:Transcription [Genetic Function]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1517480:Amplification [Molecular Biology Research Technique]
   739   C1521871:Amplification [Phenomenon or Process]
   739   C1524075:Chain [Idea or Concept]
   739   C1555029:Reverse [Idea or Concept]
   739   C1705759:Amplification [Cell or Molecular Dysfunction]
   706   C1521827:Prepare [Functional Concept]

Phrase: "isolated from proliferating cells."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1514485:Proliferating [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.73: The forward oligonucleotide primer (5'-CTGACTGCCGAGAAGTTGTGCATC-3') and the reverse primer (5'-CTGGCTCCTTTCTCTTCGCGATG-3') were designed based on the published sequence of rat cyclin D1 cDNA (20). 

Phrase: "The forward oligonucleotide primer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1953382:Forward primer [Cell]
   901   C0206415:Oligonucleotide Primer [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "(5'-CTGACTGCCGAGAAGTTGTGCATC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-CTGGCTCCTTTCTCTTCGCGATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "based on the published sequence of rat cyclin D1 cDNA (20"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   756   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0004793:Sequence [Nucleotide Sequence]
           Base Sequence
   738   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0034037:Published [Occupational Activity]
   738   C0034693:Rat, NOS [Mammal]
   738   C0034721:Rat [Mammal]
   738   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C1150565:cyclin [Molecular Function]
   738   C1416886:D1 [Gene or Genome]
   738   C1519249:Sequence [Functional Concept]
   738   C1527178:Based [Functional Concept]
   738   C1704324:Published [Intellectual Product]
   738   C1705938:Based [Idea or Concept]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.74: The 591-base pair amplification product was used for hybridization with 10g of cellular RNA extracted using the guanidine thiocyanate-phenol-chloroform method (21). 

Phrase: "The 591-base pair amplification product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "used for hybridization"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0020202:Hybridisation [Genetic Function]
   790   C1273517:used [Finding]
   790   C1300517:Hybridization [Laboratory Procedure]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "with 10g"

Phrase: "of cellular RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the guanidine thiocyanate-phenol-chloroform method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.75: Hybridization was carried out for 3h at 65C with [-32P]dCTP-labeled cyclin D1 and glyceraldehyde-3-phosphate dehydrogenase cDNA probes in QuikhybTM solutions containing denatured salmon sperm DNA. 

Phrase: "Hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020202:Hybridisation [Genetic Function]
  1000   C1300517:Hybridization [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out for 3h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   790   C1442460:3H [Temporal Concept]

Phrase: "at 65C"

Phrase: "with"

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP-labeled cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1150565:cyclin [Molecular Function]
   812   C1416886:D1 [Gene or Genome]

Phrase: "and"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase cDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   771   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   771   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   717   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]

Phrase: "probes in QuikhybTM solutions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0037633:Solutions [Substance]
   770   C0182400:Probe [Medical Device]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "denatured salmon sperm DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.76: The membrane was washed three times with 1 SSC buffer (1.5mM sodium citrate, 15mM NaCl, and 0.1% SDS) followed by another wash with 0.1SSC. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with 1 SSC buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "(1.5mM sodium citrate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   812   C0008857:Citrate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "15mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.1% SDS)"

Phrase: "followed by another wash"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0441648:Wash [Activity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with 0.1SSC."
Processing 00000000.tx.77: Hybridization signal was analyzed using the Scion Image PC program. 

Phrase: "Hybridization signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Scion Image PC program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]
Processing 00000000.tx.78: The relative level of cyclin D1 mRNA was determined based on the amount of glyceraldehyde-3-phosphate dehydrogenase mRNA in each sample. 

Phrase: "The relative level of cyclin D1 mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "determined"

Phrase: "based on the amount of glyceraldehyde-3-phosphate dehydrogenase mRNA"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   806   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   806   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   777   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   739   C0017854:Glyceraldehyde [Carbohydrate]
   739   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   739   C0031701:phosphate [Organophosphorus Compound]
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C1265611:Amount [Quantitative Concept]
   739   C1527178:Based [Functional Concept]
   739   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.79: Determination of MAP Kinase Activity-- The smooth muscle cells were plated at a density of 1.5105 cells in 6-well plates and then incubated for 5min at 37C in the presence or absence of PDGF-BB, oxLDL, and apoE. 

Phrase: "Determination of MAP Kinase Activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1148554:determination [Laboratory Procedure]
   731   C1150579:mitogen-activated protein kinase activity [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "The smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "plated at a density of 1.5105 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   750   C0162339:Cell Density [Quantitative Concept]
   750   C1166718:cells plate [Cell Component]
   744   C0007634:Cells [Cell]
   744   C0178587:density [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711   C0005971:Plate [Medical Device]
   711   C1139930:plate [Medical Device]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711   C3537155:Plate [Manufactured Object]

Phrase: "in 6-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of PDGF-BB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   731   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "oxLDL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030011:oxidize [Molecular Function]

Phrase: "and"

Phrase: "apoE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.80: Cell lysate was prepared by adding 200l of buffer containing 25mM HEPES, pH 7.5,0.2mM phenylmethylsulfonyl fluoride, 0.05% 2-mercaptoethanol, and 1% Triton X-100. 

Phrase: "Cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "prepared by adding 200l of buffer containing 25mM HEPES,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0332256:Containing [Functional Concept]
   742   C2700400:Containing [Activity]
   708   C1521827:Prepare [Functional Concept]
   708   C1883712:Add [Functional Concept]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.2mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.05% 2-mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "1% Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]
Processing 00000000.tx.81: The cell lysate was mixed with 40l of kinase buffer containing 25mM HEPES, pH 7.5,10mM magnesium acetate, 50mM ATP, and 2l of [(-32P]ATP (1.0mCi/ml). 

Phrase: "The cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "mixed with 40l of kinase buffer containing 25mM HEPES,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205430:Mixed [Functional Concept]
   742   C0332256:Containing [Functional Concept]
   742   C2700400:Containing [Activity]
   742   C3160715:Mixed [Finding]
   708 E C1421951:MIX [Gene or Genome]
   708 E C1720722:Mix [Qualitative Concept]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10mM magnesium acetate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0982266:magnesium acetate [Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "50mM ATP,"

Phrase: "and"

Phrase: "2l of [(-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "(1.0mCi/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.82: The reaction was initiated by adding 10l of PHAS-I, and incubation was continued for 10min at 30C. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "initiated by adding 10l of PHAS-I,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0254260:PHAS-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1414352:PHAS-I [Gene or Genome]
   778   C2984182:PHAS-I [Gene or Genome]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   714   C0030779:PHA [Disease or Syndrome]
   714   C0031858:PHA [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   714   C1548602:Initiate [Idea or Concept]
   714   C1704686:Initiate [Functional Concept]
   714   C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubation"

Phrase: "was"

Phrase: "continued for 10min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0549178:Continued [Idea or Concept]

Phrase: "at 30C."
Processing 00000000.tx.83: The phosphorylation reaction was terminated by adding 5l of 0.25 M phosphoric acid. 

Phrase: "The phosphorylation reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by adding 5l of 0.25 M phosphoric acid."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0031700:Phosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   760   C0031702:phosphoric acid [Inorganic Chemical]
   760   C1161325:phosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0031705:Phosphoric [Element, Ion, or Isotope]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]
   739   C1553404:terminated [Idea or Concept]
   739   C2348570:Terminated [Functional Concept]
   706   C1883712:Add [Functional Concept]
Processing 00000000.tx.84: Ten l of each reaction mixture was spotted onto chromatography paper, washed with 75mM phosphoric acid, rinsed in 95% ethanol, and then subjected to liquid scintillation counting. 

Phrase: "Ten l of each reaction mixture"

Phrase: "was"

Phrase: "spotted onto chromatography paper,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0008568:Chromatography, Paper [Laboratory Procedure]
   770   C0008550:Chromatography [Laboratory Procedure]
   770   C0030351:Paper [Manufactured Object]
   770   C1547566:Paper [Idea or Concept]
   737   C0329155:Spot [Fish]
   737   C1427618:SPOT [Gene or Genome]
   737   C1705203:Spot [Conceptual Entity]

Phrase: "washed with 75mM phosphoric acid,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0031700:Phosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   806   C0031702:phosphoric acid [Inorganic Chemical]
   806   C1161325:phosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0031705:Phosphoric [Element, Ion, or Isotope]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1548982:Washed [Idea or Concept]
   726 E C0441648:Wash [Activity]

Phrase: "rinsed in 95% ethanol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001962:Ethanol [Organic Chemical]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to liquid scintillation counting."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0681850:Subject [Group]
   726   C0750480:Count [Activity]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1705566:Count [Quantitative Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.85: Statistical Analysis-- The apoE effect on cell proliferation was assessed by two-factorial ANOVA. 

Phrase: "Statistical Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The apoE effect on cell proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "assessed by two-factorial ANOVA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C1516048:Assessed [Activity]
   760   C2826344:FACTORIAL [Research Activity]
Processing 00000000.tx.86: All other data were analyzed for statistical significance using one-way ANOVA. 

Phrase: "All"

Phrase: "other data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed for statistical significance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   833   C1709380:Statistical Significance [Quantitative Concept]
   770   C0038215:Statistical [Occupation or Discipline]
   770   C0750502:Significance [Idea or Concept]
   770   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "one-way ANOVA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709320:One-way ANOVA [Quantitative Concept]
Processing 00000000.tx.87: A p value of less than 0.05was considered to be statistically significant.  

Phrase: "A p value of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1709380:P-Value [Quantitative Concept]
   760   C1522609:Value [Quantitative Concept]

Phrase: "than 0.05was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.88: RESULTS Top Abstract Introduction Procedures Results Discussion References ApoE Inhibits PDGF-directed Smooth Muscle Cell Migration-- Using the cell migration assay described under "Experimental Procedures," 6.32.6quiescent A7r5 cells were found to be present in each HPF, indicating that 4.2% of the total amount of plated cells migrated to the lower chamber under basal conditions. 

Phrase: "RESULTS Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-directed Smooth Muscle Cell Migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   849   C2265920:smooth muscle cell migration [Cell Function]
   827   C2265821:muscle cell migration [Cell Function]
   807   C1622501:Migration, Cell [Cell Function]
   791   C0600210:Migration [Social Behavior]
   791   C1533574:Migration [Physiologic Function]
   791   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "-"

Phrase: "-"

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the cell migration assay"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C1513300:Cell Migration Assay [Laboratory Procedure]
           Migration Assay
   901   C1622501:Migration, Cell [Cell Function]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0243073:assay [Qualitative Concept]
   827   C0600210:Migration [Social Behavior]
   827   C1269647:Cell [Cell]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1533574:Migration [Physiologic Function]
   827   C1704653:Cell [Medical Device]
   827   C1881827:MIGRATION [Phenomenon or Process]
   827   C1948049:Cell [Spatial Concept]

Phrase: "described under ""Experimental Procedures,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """ 6.32.6quiescent A7r5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in each HPF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "indicating"

Phrase: "that 4.2% of the total amount of plated cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   757   C1441375:Cells.total [Cell]
   741   C1166718:cells plate [Cell Component]
   739   C0007634:Cells [Cell]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C1265611:Amount [Quantitative Concept]
   739   C3282337:Cells [Cell]
   706   C0005971:Plate [Medical Device]
   706   C1139930:plate [Medical Device]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   706   C3537155:Plate [Manufactured Object]

Phrase: "migrated to the lower chamber"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0232902:Migrated [Functional Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "under basal conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.89: The addition of PDGF enhanced A7r5 cell migration 4-fold, with 25.86.1cells observed in each HPF, representing 17.1% of the total amount of plated cells migrated to the lower chamber (Fig. 1A). 

Phrase: "The addition of PDGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "A7r5 cell migration 4-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "with 25.86.1cells"

Phrase: "observed in each HPF,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C1552990:High Power Field [Quantitative Concept]
   753   C0032863:Power [Human-caused Phenomenon or Process]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C2700149:HIGH [Intellectual Product]
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C1521738:Field [Conceptual Entity]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "17.1% of the total amount of plated cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   762   C1441375:Cells.total [Cell]
   745   C1166718:cells plate [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C1265611:Amount [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708   C0005971:Plate [Medical Device]
   708   C1139930:plate [Medical Device]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708   C3537155:Plate [Manufactured Object]

Phrase: "migrated to the lower chamber"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0232902:Migrated [Functional Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.90: Human apoE, at 25g/ml, inhibited the PDGF-induced A7r5 cell migration to the same level as that observed when the cells were incubated without PDGF (Fig. 1A). 

Phrase: "Human apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "at 25g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the PDGF-induced A7r5 cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1622501:Migration, Cell [Cell Function]
   793   C0600210:Migration [Social Behavior]
   793   C1533574:Migration [Physiologic Function]
   793   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to the same level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "as that"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated without PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.91: Significantly, at 50g/ml of apoE, the number of rat aortic smooth muscle cells migrated to the lower chamber was lower than that observed with unstimulated cells (Fig. 1A). 

Phrase: "Significantly,"

Phrase: "at 50g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "the number of rat aortic smooth muscle cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "migrated to the lower chamber"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0232902:Migrated [Functional Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "was"

Phrase: "lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "observed with unstimulated cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0439819:Unstimulated [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.92: These concentrations of apoE have no effect on cell viability as determined by dye exclusion assay. 

Phrase: "These concentrations of apoE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "have"

Phrase: "no effect on cell viability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "determined by dye exclusion assay."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   760   C0243073:assay [Qualitative Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1510438:Assay [Laboratory Procedure]
   760   C2828389:Exclusion [Activity]
Processing 00000000.tx.93: Similar results were observed when experiments were performed with human coronary artery smooth muscle cells instead of the rat A7r5 smooth muscle cells (Fig. 1B). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed with human coronary artery smooth muscle cells"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   800   C1135918:Smooth Muscle Cells [Cell]
   770   C0205042:Coronary artery [Body Part, Organ, or Organ Component]
   770   C0596981:Muscle Cells [Cell]
   770   C1267092:Muscle, Smooth [Tissue]
   770   C1269008:Coronary artery [Body Part, Organ, or Organ Component]
   767   C0427861:Human cells [Laboratory or Test Result]
   744   C0003842:Artery [Body Part, Organ, or Organ Component]
   744   C0007634:Cells [Cell]
   744   C0018787:coronary [Body Part, Organ, or Organ Component]
   744   C0026845:Muscle [Tissue]
   744   C0086418:Human [Human]
   744   C0205357:Smooth [Qualitative Concept]
   744   C0226004:artery [Body System]
   744   C0884358:Performed [Functional Concept]
   744   C3282337:Cells [Cell]
   731   C0226002:Muscular artery [Body Part, Organ, or Organ Component]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "instead of the rat A7r5 smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: Thus, these experiments demonstrated a role of apoE in inhibiting smooth muscle cell migration with or without growth factor stimulation. 

Phrase: "Thus,"

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "a role of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in inhibiting smooth muscle cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C2265920:smooth muscle cell migration [Cell Function]
   884   C2265821:muscle cell migration [Cell Function]
   840   C1622501:Migration, Cell [Cell Function]
   804   C0600210:Migration [Social Behavior]
   804   C1533574:Migration [Physiologic Function]
   804   C1881827:MIGRATION [Phenomenon or Process]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "with"

Phrase: "or without growth factor stimulation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]
Processing 00000000.tx.95: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.96: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.97: Effect of apoE on PDGF-directed migration of smooth muscle cells. 

Phrase: "Effect of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-directed migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0600210:Migration [Social Behavior]
   799   C1533574:Migration [Physiologic Function]
   799   C1881827:MIGRATION [Phenomenon or Process]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of smooth muscle cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.98: Quiescent rat A7r5 smooth muscle cells (panel A) or human coronary artery smooth muscle cells (panel B) were incubated for 30min at 37C with or without apoE and then added to Transwell membranes in 24-well plates at a density of 2104 cells/well. 

Phrase: "Quiescent rat A7r5 smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A)"

Phrase: "or"

Phrase: "human coronary artery smooth muscle cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   895   C0427861:Human cells [Laboratory or Test Result]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "with"

Phrase: "or without apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to Transwell membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C1524062:Added [Functional Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "in 24-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates at a density of 2104 cells/well."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C2347578:Cells/well [Quantitative Concept]
   767   C1166718:cells plate [Cell Component]
   750   C0162339:Cell Density [Quantitative Concept]
   744   C0005971:Plate [Medical Device]
   744   C0007634:Cells [Cell]
   744   C0178587:density [Quantitative Concept]
   744   C0205170:Well [Qualitative Concept]
   744   C1139930:plate [Medical Device]
   744   C3146287:Well [Manufactured Object]
   744   C3282337:Cells [Cell]
   744   C3537155:Plate [Manufactured Object]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.99: The lower Transwell chamber contained 0.6ml of DMEM, 0.4% FBS, with or without 10ng/ml of PDGF-BB. 

Phrase: "The lower Transwell chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "0.6ml of DMEM,"

Phrase: "0.4% FBS,"

Phrase: "with"

Phrase: "or without 10ng/ml of PDGF-BB."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   833   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   739   C0004739:BB [Geographic Area]
   739   C0005821:Platelet [Cell]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0220844:growth [Physiologic Function]
   739   C0332297:BB [Spatial Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C1441547:Derived [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3245521:derived [Idea or Concept]
Processing 00000000.tx.100: Incubation was continued for 4h at 37C. 

Phrase: "Incubation"

Phrase: "was"

Phrase: "continued for 4h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549178:Continued [Idea or Concept]
   790   C1292426:4H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.101: The number of cells that migrated to the lower surface was determined microscopically by counting in different high power fields (HPF) at a magnification of 320.

Phrase: "The number of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "migrated to the lower surface"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205148:Surface [Spatial Concept]
   760   C0232902:Migrated [Functional Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "was"

Phrase: "determined"

Phrase: "microscopically by counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "in different high power fields (HPF)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   890   C1552990:High Power Field [Quantitative Concept]
   812   C0032863:Power [Human-caused Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C2700149:HIGH [Intellectual Product]
   779   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   779   C1521738:Field [Conceptual Entity]
   779   C2346620:Field [Conceptual Entity]
   779   C2349184:Field [Conceptual Entity]
   779   C3539073:FIELD [Spatial Concept]

Phrase: "at a magnification"

Phrase: "of 320."
Processing 00000000.tx.102: Data are expressed as meanS.D. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meanS.D."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.103: (n=6). 

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.104: *, values differed from no apoE; 

Phrase: "*,"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "differed from no apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.105: PDGF-stimulated control at p<0.0001. 

Phrase: "PDGF-stimulated control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C0491336:CONTROL, PLATELET [Indicator, Reagent, or Diagnostic Aid]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at p<0.0001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.106: ApoE Inhibits PDGF-Stimulated Smooth Muscle Cell Proliferation-- Incubation of quiescent rat A7r5 aortic smooth muscle cells with PDGF resulted in a 2-to 2.5-fold induction of [3H]thymidine incorporation into their DNA in comparison with cells incubated without the growth factor (Fig. 2). 

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PDGF-Stimulated Smooth Muscle Cell Proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   849   C1658578:smooth muscle cell proliferation [Cell Function]
   827   C2246389:muscle cell proliferation [Cell Function]
   807   C0596290:Cell Proliferation [Cell Function]
   791   C0334094:Proliferation [Pathologic Function]
   791   C1514485:Proliferation [Functional Concept]

Phrase: "--"

Phrase: "Incubation of quiescent rat A7r5 aortic smooth muscle cells"

Phrase: "with PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "resulted in a 2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "to 2.5-fold induction of [3H]thymidine incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0243126:incorporation [Functional Concept]

Phrase: "into their DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated without the growth factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: The addition of 25and 50g/ml of human apoE to the culture media significantly reduced the PDGF-induced [3H]thymidine incorporation into DNA (p<0.001,Fig. 2). 

Phrase: "The addition of 25and 50g/ml of human apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1883712:Addition [Functional Concept]

Phrase: "to the culture media significantly"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0162867:Media [Tissue]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1254021:Media [Tissue]
   827   C2242979:Culture [Laboratory Procedure]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the PDGF-induced"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205263:Induced [Functional Concept]
   771   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]

Phrase: "[3H]thymidine incorporation into DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "(p<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.108: To confirm that apoE inhibition of PDGF-induced [3H]thymidine incorporation into DNA is a reflection of its ability to inhibit cell proliferation, a direct cell proliferation assay was performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that apoE inhibition of PDGF-induced"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   784   C1512280:Growth Factor Inhibition [Physiologic Function]
   784   C2249823:inhibition of growth [Organism Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "[3H]thymidine incorporation into DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "is"

Phrase: "a reflection of its ability to"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cell proliferation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "a direct cell proliferation assay"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   902   C1441554:Direct assay [Laboratory Procedure]
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0243073:assay [Qualitative Concept]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1269647:Cell [Cell]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1514485:Proliferation [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.109: The results showed that PDGF stimulated the proliferation of both rat embryonic smooth muscle cells and human coronary artery smooth muscle cells in a time-dependent manner (Fig. 3). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the proliferation of both rat embryonic smooth muscle cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1658578:smooth muscle cell proliferation [Cell Function]
   767   C2246389:muscle cell proliferation [Cell Function]
   745   C0596290:Cell Proliferation [Cell Function]
   742   C0334094:Proliferation [Pathologic Function]
   742   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "human coronary artery smooth muscle cells in a time-dependent manner"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   775   C1135918:Smooth Muscle Cells [Cell]
   756   C0596981:Muscle Cells [Cell]
   756   C1267092:Muscle, Smooth [Tissue]
   754   C0427861:Human cells [Laboratory or Test Result]
   738   C0007634:Cells [Cell]
   738   C0026845:Muscle [Tissue]
   738   C0205357:Smooth [Qualitative Concept]
   738   C3282337:Cells [Cell]
   726   C0039487:Temporal Muscle [Body Part, Organ, or Organ Component]
   726   C1275494:Temporal muscle [Body Part, Organ, or Organ Component]
   718   C0226002:Muscular artery [Body Part, Organ, or Organ Component]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.110: The addition of apoE effectively inhibited the PDGF-stimulated smooth muscle cell proliferation (p<0.001,Fig. 3). 

Phrase: "The addition of apoE effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the PDGF-stimulated smooth muscle cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   849   C1658578:smooth muscle cell proliferation [Cell Function]
   827   C2246389:muscle cell proliferation [Cell Function]
   807   C0596290:Cell Proliferation [Cell Function]
   791   C0334094:Proliferation [Pathologic Function]
   791   C1514485:Proliferation [Functional Concept]

Phrase: "(p<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.111: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.112: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.113: Effect of apoE on PDGF-induced proliferation of aortic smooth muscle cells. 

Phrase: "Effect of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced proliferation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0334094:Proliferation [Pathologic Function]
   799   C1514485:Proliferation [Functional Concept]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of aortic smooth muscle cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0003483:Aortic [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.114: Serum-starved rat A7r5 smooth muscle cells were incubated in 96-well plates (5103 cells/well) for 20h at 37C in DMEM with or without 10ng/ml of PDGF and apoE prior to the addition of 1Ci of [3H-methyl]thymidine. 

Phrase: "Serum-starved rat A7r5 smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   845   C1135918:Smooth Muscle Cells [Cell]
   818   C0596981:Muscle Cells [Cell]
   818   C1267092:Muscle, Smooth [Tissue]
   795   C0007634:Cells [Cell]
   795   C0026845:Muscle [Tissue]
   795   C0205357:Smooth [Qualitative Concept]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   724 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "incubated in 96-well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(5103 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "for 20h"

Phrase: "at 37C"

Phrase: "in DMEM"

Phrase: "with"

Phrase: "or without 10ng/ml of PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   742   C0005821:Platelet [Cell]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C0439526:/mL [Quantitative Concept]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "apoE prior to the addition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]

Phrase: "of 1Ci of [3H-methyl]thymidine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0066441:methylthymidine [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.115: The amount of [3H]thymidine incorporated into cellular DNA after 4h of incubation was determined by liquid scintillation counting. 

Phrase: "The amount of [3H]thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1442460:3H [Temporal Concept]

Phrase: "incorporated into cellular DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007634:Cellular [Cell]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0178539:Cellular [Functional Concept]

Phrase: "after 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "of incubation"

Phrase: "was"

Phrase: "determined by liquid scintillation counting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.116: Values represent the meanS.D. from five different determinations. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.D."

Phrase: "from five different determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.117: **, values differed from no apoE control at p<0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "differed from no apoE control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243148:control [Qualitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "at p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.118: ***, values differed from no apoE PDGF-stimulated control at p<0.001. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "differed from no apoE PDGF-stimulated control"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   806   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0491336:CONTROL, PLATELET [Indicator, Reagent, or Diagnostic Aid]
   757   C0683951:control factor [Quantitative Concept]
   757   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   739   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0005821:Platelet [Cell]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0220844:growth [Physiologic Function]
   739   C0243148:control [Qualitative Concept]
   739   C0523511:APOE [Laboratory Procedure]
   739   C1412481:APOE [Gene or Genome]
   739   C1441547:Derived [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1550141:Control [Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1882979:Control [Conceptual Entity]
   739   C1948023:Stimulated [Natural Phenomenon or Process]
   739   C2587213:Control [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3245521:derived [Idea or Concept]
   739   C3274648:Control [Qualitative Concept]

Phrase: "at p<0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.119: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.121: Effect of apoE on PDGF-induced proliferation of aortic smooth muscle cells. 

Phrase: "Effect of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced proliferation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0334094:Proliferation [Pathologic Function]
   799   C1514485:Proliferation [Functional Concept]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of aortic smooth muscle cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0003483:Aortic [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.122: Serum-starved rat A7r5 smooth muscle cells (panel A) or human coronary artery smooth muscle cells (panel B) were incubated in 96-well plates (5103 cells/well) in DMEM without PDGF and apoE (), or with 10ng/ml PDGF-BB in the absence () or presence () of 50g/ml apoE. 

Phrase: "Serum-starved rat A7r5 smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   845   C1135918:Smooth Muscle Cells [Cell]
   818   C0596981:Muscle Cells [Cell]
   818   C1267092:Muscle, Smooth [Tissue]
   795   C0007634:Cells [Cell]
   795   C0026845:Muscle [Tissue]
   795   C0205357:Smooth [Qualitative Concept]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   724 E C0442025:Muscular [Spatial Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A)"

Phrase: "or"

Phrase: "human coronary artery smooth muscle cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   895   C0427861:Human cells [Laboratory or Test Result]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "incubated in 96-well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(5103 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "in DMEM"

Phrase: "without PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "or with 10ng/ml PDGF-BB"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   849   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   818   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   742   C0004739:BB [Geographic Area]
   742   C0005821:Platelet [Cell]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C0332297:BB [Spatial Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3245521:derived [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "of 50g/ml apoE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.123: Cell proliferation was determined based on formation of formazan from MTS and phenazine methosulfate as detected by absorbance at 490nm. 

Phrase: "Cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "based on formation of formazan"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from MTS"

Phrase: "and"

Phrase: "phenazine methosulfate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025809:Phenazine Methosulfate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0031375:phenazine [Organic Chemical]
   861   C2917605:Phenazine [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "detected by absorbance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442726:Detected [Finding]
   790   C1268822:Absorbance [Clinical Attribute]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 490nm."
Processing 00000000.tx.124: Data represent the mean valueS.D. from five different determinations. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean valueS.D."

Phrase: "from five different determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.125: *, p<0.001versus no apoE control. 

Phrase: "*,"

Phrase: "p<0.001versus"

Phrase: "no apoE control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.126: ApoE Does Not Affect PDGF Binding to the A7r5 Rat Aortic Smooth Muscle Cells-- The mechanism by which apoE inhibits smooth muscle cell response to PDGF stimulation was investigated initially by determining if apoE interferes with PDGF binding to its receptor on smooth muscle cells. 

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "PDGF Binding to the A7r5 Rat Aortic Smooth Muscle Cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1522950:platelet-derived growth factor binding [Molecular Function]
   766   C1149299:Growth Factor Binding [Molecular Function]
   735   C0243122:binding [Functional Concept]
   735   C1145667:Binding [Activity]
   735   C1167622:Binding [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "The mechanism by which apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "smooth muscle cell response to PDGF stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "initially by determining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205265:Initially [Temporal Concept]

Phrase: "if"

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "interferes with PDGF binding"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C1522950:platelet-derived growth factor binding [Molecular Function]
   853   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1149299:Growth Factor Binding [Molecular Function]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0521102:Interferes with [Qualitative Concept]
           Interfere
   774   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   748   C0005821:Platelet [Cell]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   748   C3245521:derived [Idea or Concept]

Phrase: "to its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "on smooth muscle cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.127: The A7r5 cells were used for these experiments. 

Phrase: "The A7r5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used for these experiments."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.128: Results showed that the smooth muscle cells displayed high affinity binding with 125I-labeled PDGF-BB. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "high affinity binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0205250:High [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1299351:High [Qualitative Concept]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C2700149:HIGH [Intellectual Product]

Phrase: "with 125I-labeled PDGF-BB."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   913   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   877   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0004739:BB [Geographic Area]
   795   C0005821:Platelet [Cell]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C0332297:BB [Spatial Concept]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   795   C3245521:derived [Idea or Concept]
   712 E C1963076:Platelets [Finding]
Processing 00000000.tx.129: Excess unlabeled PDGF competitively inhibited 125I-PDGF binding to the A7r5 cells. 

Phrase: "Excess unlabeled PDGF competitively"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   877   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0005821:Platelet [Cell]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   795   C3245521:derived [Idea or Concept]
   712 E C1963076:Platelets [Finding]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "125I-PDGF binding to the A7r5 cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1522950:platelet-derived growth factor binding [Molecular Function]
   782   C1149299:Growth Factor Binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.130: In contrast, the addition of 50g/ml human apoE had no effect on 125I-PDGF binding to the A7r5 cell surface (Fig. 4). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the addition of 50g/ml human apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "had"

Phrase: "no effect on 125I-PDGF binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "to the A7r5 cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0699040:Cell surface [Cell Component]
   827   C0205148:Surface [Spatial Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.131: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.132: 4.  

Phrase: "4."
Processing 00000000.tx.133: Binding of PDGF to A7r5 rat aortic smooth muscle cells. 

Phrase: "Binding of PDGF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1522950:platelet-derived growth factor binding [Molecular Function]
   820   C1149299:Growth Factor Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   716   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to A7r5 rat aortic smooth muscle cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0003483:Aortic [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.134: The A7r5 cells were preincubated for 3h with or without apoE or PDGF prior to the addition of 120pmol/liter of 125I-PDGF. 

Phrase: "The A7r5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated for 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442460:3H [Temporal Concept]

Phrase: "with"

Phrase: "or without apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "or"

Phrase: "PDGF prior to the addition of 120pmol/liter"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   797   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   738   C0005821:Platelet [Cell]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0220844:growth [Physiologic Function]
   738   C1441547:Derived [Qualitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   738   C3245521:derived [Idea or Concept]
   712   C0456525:platelets/liter [Quantitative Concept]

Phrase: "of 125I-PDGF."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]
Processing 00000000.tx.135: The incubation was continued for 3h, the cells were washed, and 125I-PDGF bound to the cells was determined in a counter. 

Phrase: "The incubation"

Phrase: "was"

Phrase: "continued for 3h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0549178:Continued [Idea or Concept]
   790   C1442460:3H [Temporal Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "125I-PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "bound to the cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0699040:cell bound [Cell Component]
   770   C0007634:Cells [Cell]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined in a counter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0677601:Counter [Manufactured Object]
   770   C1705206:Counter [Medical Device]
Processing 00000000.tx.136: Data represent the mean valueS.D. from four different determinations. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean valueS.D."

Phrase: "from four different determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.137: *, p<0.001versus control with no apoE or PDGF preincubation. 

Phrase: "*,"

Phrase: "p<0.001versus"

Phrase: "control with no apoE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243148:control [Qualitative Concept]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "PDGF preincubation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.138: ApoE Suppression of PDGF-induced Cyclin D1 Gene Expression-- To ascertain the possibility that apoE may interfere with early events in PDGF-induced smooth muscle cell proliferation and migration, experiments were performed to explore the effect of apoE on cyclin D1 gene expression, a prerequisite step for cell transition from the G0 to G1 phase in the cell cycle (22-23). 

Phrase: "ApoE Suppression of PDGF-induced Cyclin D1 Gene Expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0151686:Growth suppression [Pathologic Function]
   736   C0221103:Suppression [Pathologic Function]
   736   C0301625:Suppression [Organism Function]
   736   C0439181:% suppression [Quantitative Concept]
   736   C0728721:suppression [Mental Process]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "the possibility"

Phrase: "that apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "interfere with early events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441471:Events [Event]
   770   C0521102:Interfere [Qualitative Concept]
   770   C1279919:Early [Temporal Concept]
   770   C3541888:Events [Classification]

Phrase: "in PDGF-induced smooth muscle cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   849   C1658578:smooth muscle cell proliferation [Cell Function]
   827   C2246389:muscle cell proliferation [Cell Function]
   807   C0596290:Cell Proliferation [Cell Function]
   791   C0334094:Proliferation [Pathologic Function]
   791   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "migration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the effect of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on cyclin D1 gene expression,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0525036:Gene, Cyclin D1 [Gene or Genome]
   923   C1413172:Cyclin D1 Gene [Gene or Genome]
   875   C1333183:Cyclin Gene [Gene or Genome]
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "a prerequisite step for cell transition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1261552:Step [Conceptual Entity]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C2825408:Step [Manufactured Object]

Phrase: "from the G0"

Phrase: "to G1 phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079395:G1 Phase [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]

Phrase: "in the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(22-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: Total RNA was isolated from A7r5 cells incubated with PDGF in the presence or absence of apoE for 6h, a time period which was reported to result in maximal cyclin D1 mRNA expression after growth factor-induced proliferation of vascular smooth muscle cells (24). 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from A7r5 cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of apoE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "for 6h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]

Phrase: "a time period"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
  1000   C0439582:Time period [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   777 E C1632851:Times [Quantitative Concept]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "which"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in maximal cyclin D1 mRNA expression"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1515670:mRNA Expression [Genetic Function]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205289:Maximal [Qualitative Concept]
   748   C0806909:Maximal [Quantitative Concept]
   748   C1150565:cyclin [Molecular Function]
   748   C1274040:Result [Functional Concept]
   748   C1416886:D1 [Gene or Genome]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "after growth factor-induced proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]

Phrase: "of vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.140: Northern blot hybridization of cellular RNA with a rat cyclin D1 cDNA probe revealed a 2.5-fold increase in cyclin D1 mRNA level when cells were challenged with PDGF without apoE (Fig. 5). 

Phrase: "Northern blot hybridization of cellular RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0599862:RNA blot hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           northern hybridization
   753   C0020202:Hybridisation [Genetic Function]
   753   C1300517:Hybridization [Laboratory Procedure]

Phrase: "with a rat cyclin D1 cDNA probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a 2.5-fold increase in cyclin D1 mRNA level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "challenged with PDGF"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]
   719   C0798503:Challenge [Clinical Attribute]
   719   C0805586:Challenge [Health Care Activity]
   719   C3274764:Challenge [Conceptual Entity]

Phrase: "without apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.141: However, the addition of apoE to the culture media in addition to PDGF reduced the growth factor-induced increase in cyclin D1 mRNA by >50% (Fig. 5). 

Phrase: "However,"

Phrase: "the addition of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "to the culture media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0162867:Media [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1254021:Media [Tissue]
   861   C2242979:Culture [Laboratory Procedure]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "in addition to PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the growth factor-induced increase in cyclin D1 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "by"

Phrase: ">50%"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.142: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.143: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.144: Effect of apoE on PDGF-induced cyclin D1 gene expression in A7r5 rat aortic smooth muscle cells. 

Phrase: "Effect of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-induced cyclin D1 gene expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0812325:Growth Factor Gene [Gene or Genome]
   827   C0525036:Gene, Cyclin D1 [Gene or Genome]
   827   C1413172:Cyclin D1 Gene [Gene or Genome]
   817   C1333183:Cyclin Gene [Gene or Genome]
   807   C0017262:Gene Expression [Genetic Function]
   791   C0017337:Gene [Gene or Genome]
   791   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in A7r5 rat aortic smooth muscle cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0003483:Aortic [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.145: Quiescent A7r5 cells, plated in 6-well dishes at a density of 1.5105 cells/well, were incubated for 6h at 37C with no stimulation (Control) or stimulation with 10ng/ml of PDGF in the presence or absence of 50g/ml apoE before RNA isolation. 

Phrase: "Quiescent A7r5 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "plated in 6-well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "dishes at a density of 1.5105 cells/well,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C2347578:Cells/well [Quantitative Concept]
   762   C2347576:Cells/dish [Quantitative Concept]
   745   C0162339:Cell Density [Quantitative Concept]
   742   C0007634:Cells [Cell]
   742   C0020498:DISH [Disease or Syndrome]
   742   C0178587:density [Quantitative Concept]
   742   C0205170:Well [Qualitative Concept]
   742   C3146287:Well [Manufactured Object]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 6h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292428:6H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "with no stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "stimulation with 10ng/ml of PDGF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2249825:stimulation of growth [Organism Function]
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 50g/ml apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "before RNA isolation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]
Processing 00000000.tx.146: Northern blot analysis was performed with 32P-labeled cyclin D1 cDNA and glyceraldehyde-3-phosphate dehydrogenase cDNA probes. 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "was"

Phrase: "performed with 32P-labeled cyclin D1 cDNA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0884358:Performed [Functional Concept]
   748   C1150565:cyclin [Molecular Function]
   748   C1416886:D1 [Gene or Genome]
   748   C1553631:32p [Medical Device]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase cDNA probes."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0182400:Probes [Medical Device]
   766 E C1704681:Probe [Gene or Genome]
   766 E C2347609:Probe [Chemical Viewed Functionally]
   766 E C3536729:Probe [Manufactured Object]
   734   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   734   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   700   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
Processing 00000000.tx.147: The relative amount of cyclin D1 mRNA present in each sample was determined based on the expression level of glyceraldehyde-3-phosphate dehydrogenase mRNA. 

Phrase: "The relative amount of cyclin D1 mRNA present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "in each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "determined"

Phrase: "based on the expression level of glyceraldehyde-3-phosphate dehydrogenase mRNA."
Meta Candidates (Total=25; Excluded=3; Pruned=0; Remaining=22)
   797   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   797   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   772   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   756   C3244092:expression level [Idea or Concept]
   754   C0428304:phosphate level [Laboratory or Test Result]
   754   C0456949:Level 3 [Intellectual Product]
   754   C1515670:mRNA Expression [Genetic Function]
   738   C0017854:Glyceraldehyde [Carbohydrate]
   738   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   738   C0031701:phosphate [Organophosphorus Compound]
   738   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1527178:Based [Functional Concept]
   738   C1547707:Level [Geographic Area]
   738   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   738   C1705938:Based [Idea or Concept]
   738   C2946261:Level [Pharmacologic Substance]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.148: Data represent average of two independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "average of two independent experiments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.149: The Northern blot data from one experiment is shown in the inset. 

Phrase: "The Northern blot data from one experiment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "shown in the inset."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.150: ApoE Inhibition of PDGF-induced MAP Kinase in Rat Aortic Smooth Muscle Cells-- An early event important for PDGF stimulation of smooth muscle cells is the activation of MAP kinase (25). 

Phrase: "ApoE Inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of PDGF-induced MAP Kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   849   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   807   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0026249:Mitogen [Pharmacologic Substance]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C1879547:Activated [Activity]
   758 E C1515877:Activate [Functional Concept]

Phrase: "in Rat Aortic Smooth Muscle Cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   804   C0003483:Aortic [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "An early event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "important for PDGF stimulation of smooth muscle cells"

Phrase: "is"

Phrase: "the activation of MAP kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1819041:protein kinase activation [Cell Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.151: Lysate obtained from cells incubated for 5min with 10ng/ml of PDGF-BB displayed a 2-to 3-fold increase in MAP kinase activity compared with extracts obtained from unstimulated cells (Fig. 6). 

Phrase: "Lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881488:Lysate [Physical Object]

Phrase: "obtained from cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1301820:Obtained [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1706701:Obtain [Activity]
   756 E C1948049:Cell [Spatial Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "incubated for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 10ng/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of PDGF-BB"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a 2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in MAP kinase activity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   884   C1150527:protein kinase activity [Molecular Function]
   865 E C2261495:protein phosphokinase activity [Molecular Function]
   862   C1752930:mitogenic activity [Cell Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "compared with extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707455:Compared [Activity]
   756   C2828366:Extract [Substance]

Phrase: "obtained from unstimulated cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0439819:Unstimulated [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.152: However, when 50g/ml of human apoE was added simultaneously with PDGF to the cell culture medium, a significant reduction in PDGF-induced MAP kinase activity was observed (p<0.01,Fig. 6). 

Phrase: "However,"

Phrase: "when"

Phrase: "50g/ml of human apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "simultaneously with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0521115:simultaneously [Temporal Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "to the cell culture medium,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   901   C0007585:Cell Culture [Laboratory Procedure]
   901   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0007634:Cell [Cell]
   827   C0009458:Medium [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0439536:Medium [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705217:Medium [Substance]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   827   C3244283:medium [Intellectual Product]

Phrase: "a significant reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in PDGF-induced MAP kinase activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   872   C1149472:growth factor activity [Molecular Function]
   861   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   821   C1150527:protein kinase activity [Molecular Function]
   813   C1537044:protein activity [Molecular Function]
   804   C1150423:kinase activity [Molecular Function]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   799   C1752930:mitogenic activity [Cell Function]
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(p<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.153: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.154: 6.  

Phrase: "6."
Processing 00000000.tx.155: Mitogen-activated protein kinase activity in A7r5 rat aortic smooth muscle cells. 

Phrase: "Mitogen-activated protein kinase activity in A7r5 rat aortic smooth muscle cells."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   810   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   770   C1150527:protein kinase activity [Molecular Function]
   753   C1150423:kinase activity [Molecular Function]
   752 E C2261495:protein phosphokinase activity [Molecular Function]
   751   C1537044:protein activity [Molecular Function]
   736   C0205177:Activity [Functional Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]
   715   C0231484:Muscular activity [Organ or Tissue Function]
   715   C1752930:mitogenic activity [Cell Function]
Processing 00000000.tx.156: 100g of cell lysate, prepared after incubating the A7r5 cells for 5min at 37C with no addition (Control) or with 10ng/ml PDGF in the presence or absence of 50g/ml apoE, was used for the phosphorylation of PHAS-I in vitro. 

Phrase: "100g of cell lysate,"

Phrase: "prepared after incubating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:incubating [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "the A7r5 cells for 5min"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "at 37C"

Phrase: "with no addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "(Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or with 10ng/ml PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   744   C0005821:Platelet [Cell]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0439526:/mL [Quantitative Concept]
   744   C1441547:Derived [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3245521:derived [Idea or Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 50g/ml apoE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "was"

Phrase: "used for the phosphorylation of PHAS-I"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0254260:PHAS-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1414352:PHAS-I [Gene or Genome]
   778   C2984182:PHAS-I [Gene or Genome]
   757   C1524063:Use of [Functional Concept]
   748   C0021966:I- [Inorganic Chemical]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1273517:used [Finding]
   714   C0030779:PHA [Disease or Syndrome]
   714   C0031858:PHA [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.157: Background phosphorylation was determined by incubating the substrates with buffer in the absence of cell lysate. 

Phrase: "Background phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "determined by incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:incubating [Laboratory Procedure]

Phrase: "the substrates with buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of cell lysate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.158: Data represents the mean valueS.D. from four different determinations. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean valueS.D."

Phrase: "from four different determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.159: *, indicates differences at p<0.01versus PDGF-stimulated cells. 

Phrase: "*,"

Phrase: "indicates"

Phrase: "differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "at p<0.01versus PDGF-stimulated cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   874   C1179870:P cell [Cell]
   813   C0007595:growth cell [Cell Function]
   791   C0007634:Cells [Cell]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.160: ApoE Inhibition of oxLDL-Stimulated Smooth Muscle Cell Migration, Proliferation, and MAP Kinase in Rat Aortic Smooth Muscle Cells-- In addition to apoE effects on PDGF-stimulated smooth muscle cell functions, the impact of apoE on oxLDL-stimulated smooth muscle cell response was also explored. 

Phrase: "ApoE Inhibition of oxLDL-Stimulated Smooth Muscle Cell Migration,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C1524058:inhibition of cell migration [Cell Function]
           Cell Migration Inhibition
   777   C0007607:Cell Migration Inhibition [Laboratory Procedure]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "Proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "MAP Kinase in Rat Aortic Smooth Muscle Cells"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1173449:Smooth muscle protein, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1879547:Activated [Activity]
   706 E C1515877:Activate [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "In addition to apoE effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "on PDGF-stimulated smooth muscle cell functions,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   874   C0920267:Platelet Function [Laboratory Procedure]
   874   C1254881:Platelet function [Cell Function]
   807   C0007613:cell functions [Cell Function]
   800   C0231484:Muscle function [Organ or Tissue Function]
   800   C0517929:muscle function [Finding]
   791   C0542341:Functions [Functional Concept]
   758 E C0031843:function [Physiologic Function]
   758 E C0700205:FUNCTION [Classification]
   758 E C1705273:Function [Intellectual Product]
   708 E C0205245:Functional [Functional Concept]
   708 E C2700217:Functional [Conceptual Entity]

Phrase: "the impact of apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "on oxLDL-stimulated smooth muscle cell response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0871261:Response [Organism Attribute]
   795   C1704632:Response [Finding]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "also"

Phrase: "explored."
Processing 00000000.tx.161: Results shown in Fig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.162: 7 indicated that apoE also inhibited the chemoattractive and mitogenic properties of oxLDL on smooth muscle cells (26, 27). 

Phrase: "7"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that apoE also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the chemoattractive"

Phrase: "and"

Phrase: "mitogenic properties of oxLDL"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "on smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.163: This inhibition was also mediated through suppression of the MAP kinase pathway (Fig. 7). 

Phrase: "This inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "mediated through suppression of the MAP kinase pathway"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1879547:Activated [Activity]
   706 E C1515877:Activate [Functional Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.164: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 7.  

Phrase: "7."
Processing 00000000.tx.166: Effects of apoE on oxLDL-stimulated smooth muscle cell migration, proliferation, and mitogen-activated protein kinase activity. 

Phrase: "Effects of apoE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on oxLDL-stimulated smooth muscle cell migration,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C2265920:smooth muscle cell migration [Cell Function]
   845   C2265821:muscle cell migration [Cell Function]
   818   C1622501:Migration, Cell [Cell Function]
   795   C0600210:Migration [Social Behavior]
   795   C1533574:Migration [Physiologic Function]
   795   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "mitogen-activated protein kinase activity."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   884   C1150527:protein kinase activity [Molecular Function]
   865 E C2261495:protein phosphokinase activity [Molecular Function]
   862   C1752930:mitogenic activity [Cell Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.167: Smooth muscle cell migration assay (panel A) was determined by incubating quiescent A7r5 cells for 30min at 37C with or without apoE and then added to Transwell membranes in which the lower chamber contained 0.6ml of DMEM, 0.4% FBS, with or without 200g/ml of oxLDL. 

Phrase: "Smooth muscle cell migration assay"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   937   C2265920:smooth muscle cell migration [Cell Function]
   884   C1513300:Cell Migration Assay [Laboratory Procedure]
           Migration Assay
   884   C2265821:muscle cell migration [Cell Function]
   840   C1622501:Migration, Cell [Cell Function]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C0600210:Migration [Social Behavior]
   804   C1510438:Assay [Laboratory Procedure]
   804   C1533574:Migration [Physiologic Function]
   804   C1881827:MIGRATION [Phenomenon or Process]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A)"

Phrase: "was"

Phrase: "determined by incubating quiescent A7r5 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C1439852:incubating [Laboratory Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "for 30min"

Phrase: "at 37C"

Phrase: "with"

Phrase: "or without apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to Transwell membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C1524062:Added [Functional Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "in which"

Phrase: "the lower chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "0.6ml of DMEM,"

Phrase: "0.4% FBS,"

Phrase: "with"

Phrase: "or without 200g/ml of oxLDL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439526:/mL [Quantitative Concept]
   714   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.168: PDGF stimulation was used as a positive control. 

Phrase: "PDGF stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   804   C1948023:Stimulation [Natural Phenomenon or Process]
   771   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "used as a positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.169: Smooth muscle cell proliferation assay (panel B) was determined by incubating quiescent A7r5 cells at 37C in DMEM without oxLDL and apoE, or with 5g/ml of oxLDL in the absence or presence of 50g/ml apoE for 24h. 

Phrase: "Smooth muscle cell proliferation assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   771   C1658578:smooth muscle cell proliferation [Cell Function]
   717   C1135918:Smooth muscle cell [Cell]
   717   C2246389:muscle cell proliferation [Cell Function]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "determined by incubating quiescent A7r5 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C1439852:incubating [Laboratory Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "at 37C"

Phrase: "in DMEM"

Phrase: "without oxLDL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030011:oxidize [Molecular Function]

Phrase: "and"

Phrase: "apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "or with 5g/ml of oxLDL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439526:/mL [Quantitative Concept]
   714   C0030011:oxidize [Molecular Function]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 50g/ml apoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.170: PDGF stimulation was used as a positive control. 

Phrase: "PDGF stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   804   C1948023:Stimulation [Natural Phenomenon or Process]
   771   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "used as a positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.171: MAP kinase activity (panel C) was determined from A7r5 cell lysate prepared after incubating the cells for 5min at 37C with no addition (control) or with 25g/ml oxLDL in the presence or absence of apoE. 

Phrase: "MAP kinase activity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   884   C1150527:protein kinase activity [Molecular Function]
   865 E C2261495:protein phosphokinase activity [Molecular Function]
   862   C1752930:mitogenic activity [Cell Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "determined from A7r5 cell lysate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "prepared after incubating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:incubating [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "the cells for 5min"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C0007634:THE CELL [Cell]
           Cells
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at 37C"

Phrase: "with no addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or with 25g/ml oxLDL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439526:/mL [Quantitative Concept]
   719   C0030011:oxidize [Molecular Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of apoE."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.172: *, p<0.01versus stimulated cells.  

Phrase: "*,"

Phrase: "p<0.01versus"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.173: DISCUSSION Top Abstract Introduction Procedures Results Discussion References Pathological studies indicated that narrowing of the coronary vessels in atherosclerosis and restenosis is related to neointimal hyperplasia, with abnormal proliferation and migration of vascular smooth muscle cells from the tunica media to the intima (28, 29). 

Phrase: "DISCUSSION Top Abstract Introduction Procedures Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Pathological studies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   964   C0919386:Pathology studies [Laboratory Procedure]
   947 E C0551718:Pathology study [Clinical Attribute]
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C0947630:studies [Laboratory Procedure]
   861   C1521733:Pathological [Functional Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that narrowing of the coronary vessels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332463:Narrowing [Spatial Concept]
   753   C0333164:narrowing [Quantitative Concept]

Phrase: "in atherosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "and"

Phrase: "restenosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333186:Restenosis [Acquired Abnormality]

Phrase: "is"

Phrase: "related to neointimal hyperplasia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0020507:Hyperplasia [Pathologic Function]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "with abnormal proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "migration of vascular smooth muscle cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   847   C2265920:smooth muscle cell migration [Cell Function]
   804   C2265821:muscle cell migration [Cell Function]
   783   C1622501:cells migration [Cell Function]
   770   C0302121:Blood cell migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from the tunica media"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0162867:Tunica Media [Tissue]
           Media
  1000   C1254021:Tunica media [Tissue]
           Media
   861   C0009458:Media [Intellectual Product]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "to the intima"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162864:Intima [Tissue]
  1000   C1256463:Intima [Tissue]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.174: The current hypothesis suggests that injury to the vascular endothelium exposes the underlying smooth muscle cells to mitogenic growth factors, thereby inducing their phenotypic conversion from the contractile nonproliferating phenotype to that of a secretory proliferating phenotype. 

Phrase: "The current hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that injury to the vascular endothelium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0178324:Injury to blood vessel NOS [Injury or Poisoning]
           Vascular injury
   753   C3263722:Injury [Injury or Poisoning]
   753   C3263723:Injury [Injury or Poisoning]

Phrase: "exposes"

Phrase: "the underlying smooth muscle cells to mitogenic growth factors,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C1135918:Smooth Muscle Cells [Cell]
   764   C0596981:Muscle Cells [Cell]
   764   C1267092:Muscle, Smooth [Tissue]
   762   C0007595:cells growth [Cell Function]
   745   C0007634:THE CELL [Cell]
           Cells
   742   C0026845:Muscle [Tissue]
   742   C0205357:Smooth [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "thereby"

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "their phenotypic conversion from the contractile nonproliferating phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439836:Conversion [Functional Concept]

Phrase: "to that"

Phrase: "of a secretory proliferating phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.175: Platelet-derived growth factor and oxLDL have been implicated to play a major role in activating both processes of smooth muscle cell migration and proliferation (30-32). 

Phrase: "Platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "oxLDL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030011:oxidize [Molecular Function]

Phrase: "have"

Phrase: "been"

Phrase: "implicated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "both processes of smooth muscle cell migration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1622501:Cell Migration Process [Cell Function]
   774   C0230625:cell processes [Cell Component]
   757 E C0007613:Cell Process [Cell Function]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "(30-32"

Phrase: ")."
Processing 00000000.tx.176: The mechanism of cell activation is related to the stimulation of MAP kinase activity (33, 34), which plays critical intermediary roles in mediating signal transduction from the membrane to the nucleus (35). 

Phrase: "The mechanism of cell activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "related to the stimulation of MAP kinase activity"
Meta Candidates (Total=29; Excluded=3; Pruned=0; Remaining=26)
   833   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   820   C2249695:stimulation of protein kinase activity [Cell Function]
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   797   C2247124:stimulation of kinase activity [Molecular Function]
   782   C1150527:protein kinase activity [Molecular Function]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   775   C0027120:Kinase-Related Protein [Amino Acid, Peptide, or Protein,Enzyme]
   775   C1833135:KINASE-RELATED PROTEIN [Gene or Genome]
   763 E C2261495:protein phosphokinase activity [Molecular Function]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1150423:kinase activity [Molecular Function]
   757   C1537044:protein activity [Molecular Function]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0439849:Related [Qualitative Concept]
   739   C0441655:Activity [Activity]
   739   C0445223:Related [Finding]
   739   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   739   C1561536:*Activity [Idea or Concept]
   739   C1879547:Activated [Activity]
   739   C1948023:Stimulation [Natural Phenomenon or Process]
   722   C1752930:mitogenic activity [Cell Function]
   706 E C0163712:Relate [Organic Chemical]
   706 E C1515877:Activate [Functional Concept]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "critical intermediary roles in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "signal transduction from the membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0037083:Signal Transduction [Cell Function]
   760   C1160185:transduction [Organism Function]
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.177: The induction of cell proliferation by MAP kinase has been shown to be a direct result of increased transcription of many immediate early genes (35, 36), including cyclin D1 that is required for cell transition from the G0 to the G1 phase in the cell cycle (37, 38). 

Phrase: "The induction of cell proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by MAP kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a direct result of increased transcription of many immediate early genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]

Phrase: "(35,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "required for cell transition"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0225340:Transitional cell [Cell]
   770   C0007634:Cell [Cell]
   770   C0599156:Transition [Cell or Molecular Dysfunction]
   770   C1269647:Cell [Cell]
   770   C1514873:Required [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2700061:Transition [Activity]

Phrase: "from the G0"

Phrase: "to the G1 phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079395:G1 Phase [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]

Phrase: "in the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.178: A possible role of apoE in modulation of vascular smooth muscle cell growth was suggested by the observation of its synthesis in quiescent but not actively proliferating vascular smooth muscle cells (39). 

Phrase: "A possible role of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "of vascular smooth muscle cell growth"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007595:Cell Growth [Cell Function]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "was"

Phrase: "suggested by the observation of its synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0220781:synthesis [Biologic Function]
   748   C0302523:Observation [Research Activity]
   748   C0700325:observation [Health Care Activity]
   748   C1883254:Synthesis [Activity]
   748   C1964257:Observation [Diagnostic Procedure]
   714   C1705535:Suggest [Idea or Concept]

Phrase: "in quiescent"

Phrase: "but"

Phrase: "not actively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "proliferating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514485:Proliferating [Functional Concept]

Phrase: "vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.179: Results described in this manuscript provided the first experimental evidence to document apoE inhibition of agonist-induced smooth muscle cell migration and proliferation. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "described in this manuscript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600659:Manuscript [Intellectual Product,Manufactured Object]
   770   C1552738:described [Idea or Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the first experimental evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332120:Evidence [Functional Concept]

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "apoE inhibition of agonist-induced smooth muscle cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   807   C1524058:inhibition of cell migration [Cell Function]
           Cell Migration Inhibition
   784   C0007607:Cell Migration Inhibition [Laboratory Procedure]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.180: This inhibition was shown to be due to apoE suppression of growth factor-stimulated MAP kinase activity and cyclin D1 gene expression in aortic smooth muscle cells. 

Phrase: "This inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to apoE suppression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C0728721:suppression [Mental Process]
   760   C1412481:APOE [Gene or Genome]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "of growth factor-stimulated MAP kinase activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   897   C1149472:growth factor activity [Molecular Function]
   890   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   835   C1150527:protein kinase activity [Molecular Function]
   822   C1537044:protein activity [Molecular Function]
   816 E C2261495:protein phosphokinase activity [Molecular Function]
   814   C1752930:mitogenic activity [Cell Function]
   812   C1150423:kinase activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cyclin D1 gene expression in aortic smooth muscle cells."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0525036:Gene, Cyclin D1 [Gene or Genome]
   790   C1413172:Cyclin D1 Gene [Gene or Genome]
   764   C0017262:Gene Expression [Genetic Function]
   762   C1333183:Cyclin Gene [Gene or Genome]
   745   C1861886:CELL Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.181: These in vitro experiments implicated a cytostatic function for apoE in the vessel wall and suggested an additional mechanism by which apoE protects against vascular occlusive diseases. 

Phrase: "These in vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "implicated"

Phrase: "a cytostatic function for apoE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "in the vessel wall"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an additional mechanism by which apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "protects against vascular occlusive diseases."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   851   C0750145:vascular occlusive disease [Disease or Syndrome]
   797   C0042373:Vascular Diseases [Disease or Syndrome]
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C1558950:VASCULAR [Finding]
   760   C1801960:Vascular [Qualitative Concept]
   760   C1947917:Occlusive [Functional Concept]
   747 E C0018939:Blood Diseases [Disease or Syndrome]
   731 E C1533163:Blood disease [Disease or Syndrome]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.182: The results of this study add to a growing list of mechanisms by which apoE is anti-atherogenic. 

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "add to a growing list of mechanisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0441712:Mechanisms [Functional Concept]
   748   C0745732:List [Conceptual Entity]
   748   C1883712:Add [Functional Concept]
   748   C3272378:LIST [Intellectual Product]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "by which apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "anti-atherogenic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C1563937:Atherogenesis [Pathologic Function]
Processing 00000000.tx.183: First, apoE reduces hyperlipidemia by mediating cholesterol clearance from circulation (1). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "reduces"

Phrase: "hyperlipidemia by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0020473:Hyperlipidaemia [Disease or Syndrome]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cholesterol clearance from circulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.184: Second, apoE suppresses foam cell formation by mediating cholesterol efflux from peripheral cells (40, 41). 

Phrase: "Second, apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "foam cell formation by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "cholesterol efflux from peripheral cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C2246761:cholesterol efflux [Cell Function]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.185: Third, apoE suppresses lipoprotein oxidation, thereby reducing oxidation-induced endothelial toxicity (42). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "lipoprotein oxidation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158919:lipoprotein oxidation [Molecular Function]
   861   C0030011:Oxidation [Molecular Function]

Phrase: "thereby"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "oxidation-induced endothelial toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0040539:toxicity [Qualitative Concept]
   812   C0600688:Toxicity [Injury or Poisoning]
   741 E C1407029:Toxic [Qualitative Concept]
   719 E C0032346:Poison [Hazardous or Poisonous Substance]
   719 E C1548769:Poison [Intellectual Product]
   719 E C1550590:poison [Idea or Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.186: Fourth, apoE inhibits lymphocyte proliferation (16), thus may limit inflammatory response in the arterial wall. 

Phrase: "Fourth,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205438:Fourth [Quantitative Concept]
  1000   C1706303:Fourth [Qualitative Concept]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "lymphocyte proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596873:lymphocyte proliferation [Cell Function]
   861   C0024264:Lymphocyte [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "may"

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "inflammatory response in the arterial wall."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1155266:Inflammatory Response [Pathologic Function]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.187: Fifth, apoE inhibits agonist-induced platelet aggregation (43), which will retard the progression of atherosclerotic lesion; 

Phrase: "Fifth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205439:Fifth [Quantitative Concept]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "agonist-induced platelet aggregation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   923   C1268819:Induced platelet aggregation [Cell Function]
   861   C0032176:Platelet aggregation [Cell Function]
   861   C0677599:Platelet aggregation [Laboratory or Test Result]
   861   C0920267:Platelet Aggregation [Laboratory Procedure]
   812   C0005821:Platelet [Cell]
   812   C0332621:Aggregation [Functional Concept]
   812   C0439168:% aggregation [Quantitative Concept]
   741 E C0205418:Aggregate [Qualitative Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "will"

Phrase: "retard"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:retard [Qualitative Concept]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "the progression of atherosclerotic lesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]

Phrase: ";"
Processing 00000000.tx.188: and sixth, apoE suppresses growth factor and oxLDL-induced smooth muscle cell migration and proliferation (this study). 

Phrase: "and"

Phrase: "sixth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205440:Sixth [Quantitative Concept]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "growth factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1521761:Factor [Functional Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2827422:Factor [Conceptual Entity]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "oxLDL-induced smooth muscle cell migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C2265920:smooth muscle cell migration [Cell Function]
   845   C2265821:muscle cell migration [Cell Function]
   818   C1622501:Migration, Cell [Cell Function]
   795   C0600210:Migration [Social Behavior]
   795   C1533574:Migration [Physiologic Function]
   795   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.189: Taken together, these apoE activities may explain the versatility of this apolipoprotein in conferring protection against various forms of vascular diseases, including cholesterol-induced atherosclerosis (2), angioplasty- or injury-induced restenosis (10, 12, 44), and transplant-induced accelerated arteriosclerosis (46). 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these apoE activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "explain"

Phrase: "the versatility of this apolipoprotein"

Phrase: "in conferring protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]

Phrase: "against various forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of vascular diseases,"
Meta Candidates (Total=17; Excluded=12; Pruned=0; Remaining=5)
  1000   C0042373:Vascular Diseases [Disease or Syndrome]
   950 E C0018939:Blood Diseases [Disease or Syndrome]
   933 E C1533163:Blood disease [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cholesterol-induced atherosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0004153:Atherosclerosis [Disease or Syndrome]
   755 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "angioplasty-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162577:Angioplasty [Therapeutic or Preventive Procedure]
  1000   C1548817:Angioplasty [Health Care Activity]

Phrase: "or"

Phrase: "injury-induced restenosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333186:Restenosis [Acquired Abnormality]

Phrase: "(10,"

Phrase: "12,"

Phrase: "44"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "transplant-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040732:Transplant [Therapeutic or Preventive Procedure]
  1000   C0332835:Transplant [Tissue]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "accelerated arteriosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003850:Arteriosclerosis [Disease or Syndrome]
   789 E C0333477:Arteriosclerotic [Functional Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.190: In addition to its cell regulatory functions in the cardiovascular system, apoE has also been shown to modulate normal physiology and pathophysiology of other cells and tissues. 

Phrase: "In addition to its cell regulatory functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   913   C0007613:cell functions [Cell Function]
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: "in the cardiovascular system,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0007226:Cardiovascular system [Body System]
           Cardiovascular
  1000   C0425560:CARDIOVASCULAR SYSTEM [Finding]
  1000   C1269562:Cardiovascular system [Body System]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "normal physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "and"

Phrase: "pathophysiology of other cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031847:pathophysiology [Functional Concept]
   770   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.191: For example, apoE suppresses steroidogenesis in adrenals and ovaries (47-49). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "steroidogenesis in adrenals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597513:steroidogenesis [Molecular Function]

Phrase: "and"

Phrase: "ovaries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0029939:Ovaries [Body Part, Organ, or Organ Component]
  1000   C0227898:ovaries [Body Part, Organ, or Organ Component]
   966 E C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "(47-49"

Phrase: ")."
Processing 00000000.tx.192: ApoE is also expressed in the brain, where the apoE4 allele is correlated with an increased risk for late onset Alzheimer's disease (50). 

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "expressed in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "where"

Phrase: "the apoE4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "correlated with an increased risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "for late onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.193: The relationship between apoE genotype and Alzheimer's disease is related to apoE interaction with -amyloid peptide and with in regulation of fibrillogenesis (50, 51). 

Phrase: "The relationship between apoE genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "related to apoE interaction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1704675:Interaction [Functional Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "with -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of fibrillogenesis"

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.194: The ability of different apoE isoforms to regulate neurite outgrowth from dorsal root ganglion neurons (52) and to induce neurotoxicity (53, 54) also has been implicated to play a significant role in Alzheimer's disease. 

Phrase: "The ability of different apoE isoforms to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "regulate"

Phrase: "neurite outgrowth from dorsal root ganglion neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C3158384:neurite outgrowth [Cell Function]
   748   C0085103:Neurite [Cell Component]

Phrase: "(52"

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(53,"

Phrase: "54"

Phrase: ")"

Phrase: "also"

Phrase: "has"

Phrase: "been"

Phrase: "implicated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a significant role in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.195: The ability of apoE to modulate such diverse cell functions appears to be related to its ability in modulating cell signal transduction pathways in a cell- and tissue-specific manner. 

Phrase: "The ability of apoE to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "such diverse cell functions"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0007613:cell functions [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0542341:Functions [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "related to its ability"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0085732:Ability [Organism Attribute]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in modulating cell signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0086982:Signal Transduction Pathways [Molecular Function]
   853   C0037080:Signal Pathways [Molecular Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "in a cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "tissue-specific manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1955394:Tissue specific [Body Substance]
Processing 00000000.tx.196: For example, the suppressive effect of apoE on steroidogenesis in adrenals and ovaries is mediated through inhibition of cyclic AMP signaling mechanisms (47-49). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the suppressive effect of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on steroidogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597513:steroidogenesis [Molecular Function]

Phrase: "in adrenals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ovaries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0029939:Ovaries [Body Part, Organ, or Organ Component]
  1000   C0227898:ovaries [Body Part, Organ, or Organ Component]
   966 E C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "mediated through inhibition of cyclic AMP signaling mechanisms"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   815   C1155589:cyclic AMP-mediated signaling [Molecular Function]
   770   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0037083:Signaling [Cell Function]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0439596:Cyclic [Temporal Concept]
   744   C0441712:Mechanisms [Functional Concept]
   744   C1511572:Cyclic [Temporal Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
   744   C3537152:signaling [Biologic Function]
   711 E C1706376:Mechanism [Manufactured Object]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "(47-49"

Phrase: ")."
Processing 00000000.tx.197: In contrast, apoE has no effect on cyclic AMP pathway in lymphocytes, but its inhibition of lymphocyte proliferation was shown to be mediated by suppression of other early cell signaling events that lead to cell arrest at the G1a/G1b boundary (55-57). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "has"

Phrase: "no effect on cyclic AMP pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in lymphocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "but"

Phrase: "its inhibition of lymphocyte proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   926   C2255831:inhibition of lymphocyte proliferation [Cell Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mediated by suppression of other early cell signaling events"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   764   C0037083:Cell Signaling [Cell Function]
           Signaling
   742   C0007634:Cell [Cell]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0441471:Events [Event]
   742   C0728721:suppression [Mental Process]
   742   C1269647:Cell [Cell]
   742   C1279919:Early [Temporal Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3537152:signaling [Biologic Function]
   742   C3541888:Events [Classification]
   708 E C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "lead to cell arrest"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0007634:Cell [Cell]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0237477:Arrest [Temporal Concept]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C1269647:Cell [Cell]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "at the G1a/G1b boundary"

Phrase: "(55-57"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.198: The mechanism for apoE inhibition of smooth muscle cell proliferation and migration reported herein is different from the apoE effect on lymphocyte proliferation. 

Phrase: "The mechanism for apoE inhibition of smooth muscle cell proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "herein"

Phrase: "is"

Phrase: "different from the apoE effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "on lymphocyte proliferation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596873:lymphocyte proliferation [Cell Function]
   861   C0024264:Lymphocyte [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.199: The smooth muscle cell effect is mediated via inhibition of MAP kinase activity and cyclin D1 activation, resulting in the prevention of cell entry from G0 to G1 phase. 

Phrase: "The smooth muscle cell effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]
   756   C1135918:Smooth muscle cell [Cell]

Phrase: "is"

Phrase: "mediated via inhibition of MAP kinase activity"
Meta Candidates (Total=28; Excluded=2; Pruned=0; Remaining=26)
   849   C1150579:mitogen-activated protein kinase activity [Molecular Function]
           mitogen activated kinase activity
   832   C2263115:inhibition of protein kinase activity [Cell Function]
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   807   C2247121:inhibition of kinase activity [Molecular Function]
   790   C1150527:protein kinase activity [Molecular Function]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   771 E C2261495:protein phosphokinase activity [Molecular Function]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1150423:kinase activity [Molecular Function]
   762   C1537044:protein activity [Molecular Function]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1879547:Activated [Activity]
   742   C3463820:Inhibition [Activity]
   726   C1752930:mitogenic activity [Cell Function]
   708 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "cyclin D1 activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1879547:Activation [Activity]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulting in the prevention of cell entry"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0332294:Resulting in [Functional Concept]
   748   C0007634:Cell [Cell]
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C0678226:resulting [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1705654:Entry [Intellectual Product]
   748   C1706420:PREVENTION [Research Activity]
   748   C1948049:Cell [Spatial Concept]
   748   C2700409:prevention [Qualitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "from G0"

Phrase: "to G1 phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079395:G1 Phase [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.200: Other studies revealed that apoE suppresses agonist-induced platelet aggregation by activation of nitric oxide synthesis (43). 

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "agonist-induced platelet aggregation by activation of nitric oxide synthesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C3544657:activation of platelet aggregation [Cell Function]
   782   C1268819:Induced platelet aggregation [Cell Function]
   760   C0032176:Platelet aggregation [Cell Function]
   760   C0677599:Platelet aggregation [Laboratory or Test Result]
   760   C0920267:Platelet Aggregation [Laboratory Procedure]
   757   C0032173:Platelet Activation [Organ or Tissue Function]
   739   C0005821:Platelet [Cell]
   739   C0332621:Aggregation [Functional Concept]
   739   C0439168:% aggregation [Quantitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.201: ApoE also stimulates nitric-oxide synthase in human macrophages (58). 

Phrase: "ApoE also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "stimulates"

Phrase: "nitric-oxide synthase in human macrophages"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   847   C0669372:Macrophage Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   847   C1417760:NITRIC OXIDE SYNTHASE, MACROPHAGE [Gene or Genome]
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.202: Interestingly, nitric oxide has been shown to inhibit migration and proliferation of vascular smooth muscle cells (59). 

Phrase: "Interestingly,"

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "proliferation of vascular smooth muscle cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   847   C1658578:smooth muscle cell proliferation [Cell Function]
   804   C2246389:muscle cell proliferation [Cell Function]
   783   C0700080:Vascular proliferation [Pathologic Function]
   767   C0596290:Cell Proliferation [Cell Function]
   753   C0334094:Proliferation [Pathologic Function]
   753   C1514485:Proliferation [Functional Concept]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.203: Whether the effects of apoE on smooth muscle cells reported here are related to its effect on nitric oxide production remains to be determined. 

Phrase: "Whether"

Phrase: "the effects of apoE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "related to its effect"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "on nitric oxide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.204: The diverse effects of apoE on cell signaling mechanisms may be related to its ability to bind various different receptors on the cell surface. 

Phrase: "The diverse effects of apoE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on cell signaling mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: "may"

Phrase: "be"

Phrase: "related to its ability to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0085732:Ability [Organism Attribute]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "various different receptors on the cell surface."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   757   C1514760:Receptor Cell [Cell]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.205: Currently identified receptors capable of binding apoE include LDL receptor, LRP, gp330/megalin, the VLDL receptor, apoE receptor-2, LR11, and LR7/8 (60, 61). 

Phrase: "Currently identified receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "capable of binding apoE"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "LDL receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034821:LDL Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1149327:LDL receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "LRP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: "gp330/megalin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0284555:Megalin [Amino Acid, Peptide, or Protein,Receptor]
   861   C1416914:MEGALIN [Gene or Genome]

Phrase: "the VLDL receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0078394:VLDL receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1152819:VLDL receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "apoE receptor-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0052198:Apo E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1412481:APOE [Gene or Genome]

Phrase: "LR11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450776:LR11 [Body Location or Region]
  1000   C1420312:LR11 [Gene or Genome]

Phrase: "and"

Phrase: "LR7/8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450772:LR7 [Body Location or Region]

Phrase: "(60,"

Phrase: "61"

Phrase: ")."
Processing 00000000.tx.206: Whereas ligand binding to these receptors usually results in its internalization and degradation in the lysosomes, the potential for signal transduction via ligand interaction with these receptors has not been fully appreciated. 

Phrase: "Whereas"

Phrase: "ligand binding to these receptors usually"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0597358:receptor ligand binding [Molecular Function]
           Receptor Binding
   790   C1517880:Ligand Binding [Molecular Function]
   767   C1621296:receptor ligand [Molecular Function]
   753   C0023688:Ligand [Chemical]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "results in its internalization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871786:internalization [Mental Process]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "degradation in the lysosomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "the potential for signal transduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "via ligand interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "with these receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "appreciated."
Processing 00000000.tx.207: There are reports that lactoferrin, lipoprotein lipase, and Pseudomonas exotoxin A binding to LRP on macrophages resulted in a pertussis toxin-sensitive G protein-mediated increase in intracellular calcium ion and inositol triphosphate (62). 

Phrase: "There"

Phrase: "are"

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that lactoferrin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022942:Lactoferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416933:LACTOFERRIN [Gene or Genome]

Phrase: "lipoprotein lipase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023816:LIPOPROTEIN LIPASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416902:LIPOPROTEIN LIPASE [Gene or Genome]
   861   C0023764:Lipase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Pseudomonas exotoxin A binding to LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "on macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "resulted in a pertussis toxin-sensitive G protein-mediated increase"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   760   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   760   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   739   C0043167:Pertussis [Disease or Syndrome]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0332324:Sensitive [Functional Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C0442805:Increase [Functional Concept]
   739   C1550474:sensitive [Idea or Concept]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "in intracellular calcium ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596235:Calcium ion [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0022023:Ion [Element, Ion, or Isotope]
   827   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "inositol triphosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0815032:inositol triphosphate [Carbohydrate]
   861   C0146894:triphosphate [Inorganic Chemical]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.208: Significant to the current study is the report that interaction of the 39-kDa receptor-associated protein or anti-LRP with LRP on vascular smooth muscle cells resulted in inhibition of cell migration (63). 

Phrase: "Significant to the current study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]

Phrase: "is"

Phrase: "the report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that interaction of the 39-kDa receptor-associated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0872079:interaction protein [Molecular Function]
   742   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "anti-LRP with LRP"

Phrase: "on vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "resulted in inhibition of cell migration"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   882   C1524058:inhibition of cell migration [Cell Function]
           Cell Migration Inhibition
   820   C0007607:Cell Migration Inhibition [Laboratory Procedure]
   790   C1622501:Migration, Cell [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0600210:Migration [Social Behavior]
   753   C1269647:Cell [Cell]
   753   C1533574:Migration [Physiologic Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1881827:MIGRATION [Phenomenon or Process]
   753   C1948049:Cell [Spatial Concept]
   753   C3463820:Inhibition [Activity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.209: Whether apoE inhibition of ligand-induced smooth muscle cell migration and proliferation is mediated by LRP, or other members of the LDL receptor gene family present on these cells, such as the VLDL receptor (45), remains to be determined.  

Phrase: "Whether"

Phrase: "apoE inhibition of ligand-induced smooth muscle cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   807   C1524058:inhibition of cell migration [Cell Function]
           Cell Migration Inhibition
   784   C0007607:Cell Migration Inhibition [Laboratory Procedure]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "is"

Phrase: "mediated by LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C3540560:LRP [Gene or Genome]

Phrase: "or"

Phrase: "other members of the LDL receptor gene family present"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C0086282:Family Members [Family Group]
   745 E C1611821:Family Member [Intellectual Product]
   742   C0680022:members [Population Group]
   708 E C2698041:Member [Professional or Occupational Group]

Phrase: "on these cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "such as the VLDL receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0078394:VLDL receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1152819:VLDL receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.210: FOOTNOTES * This research was supported in part by funds from the National Institutes of Health (Grant DK40917) and the Japan Research Foundation for Clinical Pharmacology.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by funds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016820:Funds [Quantitative Concept]

Phrase: "from the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(Grant DK40917"

Phrase: ")"

Phrase: "and"

Phrase: "the Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Foundation for Clinical Pharmacology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016617:Foundation [Organization]
Processing 00000000.tx.211: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.212: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.213: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.214: To whom correspondence should be addressed: Dept. of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, 231Bethesda Ave., Cincinnati, OH 45267-0529.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "Laboratory Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Cincinnati College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "231Bethesda Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Cincinnati,"

Phrase: "OH 45267-0529.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0796520:TEL [Gene or Genome]
   812   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.215: 513-558-9152; 

Phrase: "513-558-9152"

Phrase: ";"
Processing 00000000.tx.216: Fax: 513-558-2141; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "513-558-2141"

Phrase: ";"
Processing 00000000.tx.217: E-mail: Huidy{at}email.uc.edu . The abbreviations used are: apo, apolipoprotein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Huidy{at}email.uc.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "apo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apolipoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.218: VLDL, very low density lipoproteins; 

Phrase: "VLDL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523560:VLDL [Laboratory Procedure]

Phrase: "very low density lipoproteins"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0023825:Very-Low-Density Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   923   C0023823:Low-Density Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   861   C0442811:Very low [Finding]
   812   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205251:low [Qualitative Concept]
   812   C0442824:Very [Qualitative Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.219: IDL, intermediate density lipoproteins; 

Phrase: "IDL,"

Phrase: "intermediate density lipoproteins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0065063:Lipoproteins, Intermediate Density [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.220: LDL, low density lipoproteins; 

Phrase: "LDL,"

Phrase: "low density lipoproteins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023823:Low-Density Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.221: oxLDL, oxidized low density lipoproteins; 

Phrase: "oxLDL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0348035:oxidized LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030011:oxidize [Molecular Function]

Phrase: "oxidized low density lipoproteins"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   966   C0348035:oxidized low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0023823:Low-Density Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   812   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205251:low [Qualitative Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]
   779   C0030011:oxidize [Molecular Function]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.222: PDGF, platelet-derived growth factor; 

Phrase: "PDGF,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: ";"
Processing 00000000.tx.223: PDGF-BB, homodimer of PDGF B polypeptide; 

Phrase: "PDGF-BB,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "homodimer of PDGF B polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C0072480:Platelet-Derived Growth Factor B [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.224: MAP kinase, mitogen-activated protein kinase; 

Phrase: "MAP kinase,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.225: DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.226: PHAS-I, insulin-regulated phosphorylated heat- and acid-stable protein; 

Phrase: "PHAS-I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0254260:PHAS-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414352:PHAS-I [Gene or Genome]
  1000   C2984182:PHAS-I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "phosphorylated heat-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "acid-stable protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.227: FBS, fetal bovine serum; 

Phrase: "FBS,"

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.228: HPF, high power fields; 

Phrase: "HPF,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1552990:High Power Field [Quantitative Concept]
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   793   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   793   C1521738:Field [Conceptual Entity]
   793   C2346620:Field [Conceptual Entity]
   793   C2349184:Field [Conceptual Entity]
   793   C3539073:FIELD [Spatial Concept]

Phrase: "high power fields"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1552990:High Power Field [Quantitative Concept]
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   793   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   793   C1521738:Field [Conceptual Entity]
   793   C2346620:Field [Conceptual Entity]
   793   C2349184:Field [Conceptual Entity]
   793   C3539073:FIELD [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.229: MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-4-sulfophenyl)-2H-tetrazolium salt LRP, low density lipoprotein receptor-related protein.  

Phrase: "MTS,"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(3-carboxymethoxyphenyl"

Phrase: ")-"

Phrase: "2-4-sulfophenyl"

Phrase: ")-"

Phrase: "2H-tetrazolium salt LRP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3540560:LRP [Gene or Genome]

Phrase: "low density lipoprotein receptor-related protein."
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]
Processing 00000000.tx.230: REFERENCES Top Abstract Introduction Procedures Results Discussion References Mahley, R. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.231: W. 

Phrase: "W."
Processing 00000000.tx.232: (1988) Science 240, 622-630[Medline] [OrderarticleviaInfotrieve] Shimano, H., Yamada, N., Katsuki, M., Yamamoto, K., Gotoda, T., Harada, K., Shimada, M., and Yazaki, Y. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Science 240,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "622-630"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shimano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Katsuki,"

Phrase: "M."

Phrase: ","

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gotoda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shimada,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Yazaki,"

Phrase: "Y."
Processing 00000000.tx.233: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.234: Natl. 

Phrase: "Natl."
Processing 00000000.tx.235: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.236: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.237: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.238: 89, 1750-1754[Abstract] Shimano, H., Yamada, N., Katsuki, M., Yamamoto, K., Gotoda, T., Harada, K., Shimada, M., and Yazaki, Y. 

Phrase: "89,"

Phrase: "1750-1754"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shimano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Katsuki,"

Phrase: "M."

Phrase: ","

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gotoda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shimada,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Yazaki,"

Phrase: "Y."
Processing 00000000.tx.239: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.240: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.241: Invest. 

Phrase: "Invest."
Processing 00000000.tx.242: 90, 2084-2091[Medline] [OrderarticleviaInfotrieve] Zhang, S. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "2084-2091"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.243: H., Reddick, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Reddick,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.244: L., Piedrahita, J. 

Phrase: "L., Piedrahita,"

Phrase: "J."
Processing 00000000.tx.245: A., and Maeda, N. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.246: (1992) Science 258, 468-471[Medline] [OrderarticleviaInfotrieve] Plump, A. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "468-471"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Plump,"

Phrase: "A."
Processing 00000000.tx.247: S., Smith, J. 

Phrase: "S."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.248: D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. 

Phrase: "D."

Phrase: ","

Phrase: "Hayek,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aalto-Setala,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Walsh,"

Phrase: "A.,"

Phrase: "Verstuyft,"

Phrase: "J."
Processing 00000000.tx.249: G., Rubin, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "E."
Processing 00000000.tx.250: M., and Breslow, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Breslow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511325:Breslow [Clinical Attribute]

Phrase: "J."
Processing 00000000.tx.251: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.252: (1992) Cell 71, 343-353[Medline] [OrderarticleviaInfotrieve] Reddick, R. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell 71,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450389:71 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "343-353"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Reddick,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.253: L., Zhang, S. 

Phrase: "L., Zhang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.254: H., and Maeda, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.255: (1994) Arterioscler. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.256: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.257: 14, 141-147[Abstract] Zhang, S. 

Phrase: "14,"

Phrase: "141-147"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zhang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.258: H., Reddick, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Reddick,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.259: L., Burkey, B., and Maeda, N. 

Phrase: "L., Burkey,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.260: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.261: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.262: Invest. 

Phrase: "Invest."
Processing 00000000.tx.263: 94, 937-945[Medline] [OrderarticleviaInfotrieve] Kashyap, V. 

Phrase: "94,"

Phrase: "937-945"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kashyap,"

Phrase: "V."
Processing 00000000.tx.264: S., Santamarina-Fojo, S., Brown, D. 

Phrase: "S."

Phrase: ","

Phrase: "Santamarina-Fojo,"

Phrase: "S."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D."
Processing 00000000.tx.265: R., Parrott, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Parrott,"

Phrase: "C."
Processing 00000000.tx.266: L., Applebaum-Bowden, D., Meyn, S., Talley, G., Paigen, B., Maeda, N., and Brewer, H. 

Phrase: "L., Applebaum-Bowden,"

Phrase: "D."

Phrase: ","

Phrase: "Meyn,"

Phrase: "S."

Phrase: ","

Phrase: "Talley,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Paigen,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Maeda,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.267: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.268: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.269: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.270: Invest. 

Phrase: "Invest."
Processing 00000000.tx.271: 96, 1612-1620[Medline] [OrderarticleviaInfotrieve] Shimano, H., Ohsuga, J., Shimada, M., Namba, Y., Gotoda, T., Harada, K., Katsuki, M., Yazaki, Y., and Yamada, N. 

Phrase: "96,"

Phrase: "1612-1620"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shimano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohsuga,"

Phrase: "J.,"

Phrase: "Shimada,"

Phrase: "M."

Phrase: ","

Phrase: "Namba,"

Phrase: "Y.,"

Phrase: "Gotoda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Katsuki,"

Phrase: "M."

Phrase: ","

Phrase: "Yazaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Yamada,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.272: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.273: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.274: Invest. 

Phrase: "Invest."
Processing 00000000.tx.275: 95, 469-476[Medline] [OrderarticleviaInfotrieve] Seo, H. 

Phrase: "95,"

Phrase: "469-476"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.276: S., Lombardi, D. 

Phrase: "S."

Phrase: ","

Phrase: "Lombardi,"

Phrase: "D."
Processing 00000000.tx.277: M., Polinsky, P., Powell-Braxton, L., Bunting, S., Schwartz, S. 

Phrase: "M."

Phrase: ","

Phrase: "Polinsky,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Powell-Braxton,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bunting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326922:Bunting [Bird]

Phrase: "S."

Phrase: ","

Phrase: "Schwartz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.278: M., and Rosenfeld, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Rosenfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.279: E. 

Phrase: "E."
Processing 00000000.tx.280: (1997) Arterioscler. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.281: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.282: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.283: Biol. 

Phrase: "Biol."
Processing 00000000.tx.284: 17, 3593-3601[Abstract/Free FullText] Dansky, H. 

Phrase: "17,"

Phrase: "3593-3601"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dansky,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.285: M., Charlton, S. 

Phrase: "M."

Phrase: ","

Phrase: "Charlton,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.286: A., Harper, M. 

Phrase: "A.,"

Phrase: "Harper,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: M., and Smith, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.288: D. 

Phrase: "D."
Processing 00000000.tx.289: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.290: Natl. 

Phrase: "Natl."
Processing 00000000.tx.291: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.292: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.293: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.294: 94, 4642-4646[Abstract/Free FullText] van Bockxmeer, F. 

Phrase: "94,"

Phrase: "4642-4646"

Phrase: "[Abstract/Free FullText"

Phrase: "] van Bockxmeer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.295: M., Mamotte, C. 

Phrase: "M."

Phrase: ","

Phrase: "Mamotte,"

Phrase: "C."
Processing 00000000.tx.296: D.S., Gibbons, F. 

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gibbons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020410:Gibbons [Mammal]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.297: R., and Taylor, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Taylor,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.298: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.299: (1994) Atherosclerosis 110, 195-202[Medline] [OrderarticleviaInfotrieve] Bornfeldt, K., Raines, E., Nakano, T., Graves, L., Krebs, E., and Ross, R. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Atherosclerosis 110,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004153:Atherosclerosis [Disease or Syndrome]
   789 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "195-202"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bornfeldt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Raines,"

Phrase: "E.,"

Phrase: "Nakano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Graves,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Krebs,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.300: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.301: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.302: Invest. 

Phrase: "Invest."
Processing 00000000.tx.303: 93, 1266-1274[Medline] [OrderarticleviaInfotrieve] Kundra, V., Escobedo, J. 

Phrase: "93,"

Phrase: "1266-1274"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kundra,"

Phrase: "V.,"

Phrase: "Escobedo,"

Phrase: "J."
Processing 00000000.tx.304: A., Kazlauskas, A., Kim, H. 

Phrase: "A.,"

Phrase: "Kazlauskas,"

Phrase: "A.,"

Phrase: "Kim,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.305: K., Rhee, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rhee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.306: G., Williams, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Williams,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.307: T., and Zetter, B. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Zetter,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.308: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.309: (1994) Nature 367, 474-476[CrossRef][Medline] [OrderarticleviaInfotrieve] Graf, K., Xi, X. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 367,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "474-476"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Graf,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538925:GRAF [Gene or Genome]
  1000   C3273452:GRAF [Gene or Genome]
  1000   C3273455:GRAF [Amino Acid, Peptide, or Protein]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Xi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720296:Xi [Intellectual Product]

Phrase: "X."
Processing 00000000.tx.310: P., Yang, D., Fleck, E., Hsueh, W. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "Fleck,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165528:fleck [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "E.,"

Phrase: "Hsueh,"

Phrase: "W."
Processing 00000000.tx.311: A., and Law, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Law,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023150:Law [Regulation or Law]
  1000   C0220866:Law [Regulation or Law]
  1000   C0728724:law [Regulation or Law]
  1000   C1947938:Law [Intellectual Product]
  1000   C1947939:Law [Occupation or Discipline]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.312: E. 

Phrase: "E."
Processing 00000000.tx.313: (1997) Hypertension 29, 334-339[Abstract/Free FullText] Hui, D. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Hypertension 29,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: "334-339"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hui,"

Phrase: "D."
Processing 00000000.tx.314: Y., Harmony, J. 

Phrase: "Y.,"

Phrase: "Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699798:harmony [Social Behavior]
  1000   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.315: A.K., Innerarity, T. 

Phrase: "A.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Innerarity,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.316: L., and Mahley, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.317: W. 

Phrase: "W."
Processing 00000000.tx.318: (1980) J. 

Phrase: "(1980"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.319: Biol. 

Phrase: "Biol."
Processing 00000000.tx.320: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.321: 255, 11775-11781[Abstract/Free FullText] Rall, S. 

Phrase: "255,"

Phrase: "11775-11781"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.322: C., Weisgraber, K. 

Phrase: "C., Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.323: H., and Mahley, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.324: W. 

Phrase: "W."
Processing 00000000.tx.325: (1986) Methods Enzymol. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.326: 128, 273-287[Medline] [OrderarticleviaInfotrieve] Havel, R. 

Phrase: "128,"

Phrase: "273-287"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Havel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.327: J., Eder, H. 

Phrase: "J.,"

Phrase: "Eder,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.328: A., and Bragdon, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Bragdon,"

Phrase: "J."
Processing 00000000.tx.329: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.330: (1955) J. 

Phrase: "(1955"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.331: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.332: Invest. 

Phrase: "Invest."
Processing 00000000.tx.333: 34, 1345-1353[Medline] [OrderarticleviaInfotrieve] Law, R. 

Phrase: "34,"

Phrase: "1345-1353"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Law,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023150:Law [Regulation or Law]
  1000   C0220866:Law [Regulation or Law]
  1000   C0728724:law [Regulation or Law]
  1000   C1947938:Law [Intellectual Product]
  1000   C1947939:Law [Occupation or Discipline]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.334: E., Meehan, W. 

Phrase: "E.,"

Phrase: "Meehan,"

Phrase: "W."
Processing 00000000.tx.335: P., Xi, X. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Xi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720296:Xi [Intellectual Product]

Phrase: "X."
Processing 00000000.tx.336: P., Graf, K., Wuthrich, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Graf,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1538925:GRAF [Gene or Genome]
  1000   C3273452:GRAF [Gene or Genome]
  1000   C3273455:GRAF [Amino Acid, Peptide, or Protein]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wuthrich,"

Phrase: "D."
Processing 00000000.tx.337: A., Coats, W., Faxon, D., and Hsueh, W. 

Phrase: "A.,"

Phrase: "Coats,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0453946:coats [Manufactured Object]
   966 E C1522408:Coat [Qualitative Concept]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "W.,"

Phrase: "Faxon,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Hsueh,"

Phrase: "W."
Processing 00000000.tx.338: A. 

Phrase: "A."
Processing 00000000.tx.339: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.340: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.341: Invest. 

Phrase: "Invest."
Processing 00000000.tx.342: 98, 1897-1905[Abstract/Free FullText] Bianchi, S., Fabiani, S., Muratori, M., Arnold, A., Sakaguchi, K., Miki, T., and Brandi, M. 

Phrase: "98,"

Phrase: "1897-1905"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bianchi,"

Phrase: "S."

Phrase: ","

Phrase: "Fabiani,"

Phrase: "S."

Phrase: ","

Phrase: "Muratori,"

Phrase: "M."

Phrase: ","

Phrase: "Arnold,"

Phrase: "A.,"

Phrase: "Sakaguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Miki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2681565:MIKI [Gene or Genome]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Brandi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.343: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.344: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.345: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.346: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.347: Commun. 

Phrase: "Commun."
Processing 00000000.tx.348: 204, 691-700[CrossRef][Medline] [OrderarticleviaInfotrieve] Chomczynski, P., and Sacchi, N. 

Phrase: "204,"

Phrase: "691-700"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chomczynski,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sacchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.349: (1987) Anal. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.350: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.351: 162, 156-159[CrossRef][Medline] [OrderarticleviaInfotrieve] Won, K. 

Phrase: "162,"

Phrase: "156-159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Won,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1555430:Won [Quantitative Concept]
   966 E C3538717:WIN [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.352: A., Xiong, Y., Beach, D., and Gilman, M. 

Phrase: "A.,"

Phrase: "Xiong,"

Phrase: "Y.,"

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Gilman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.353: Z. 

Phrase: "Z."
Processing 00000000.tx.354: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.355: Natl. 

Phrase: "Natl."
Processing 00000000.tx.356: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.357: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.358: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.359: 89, 9910-9914[Abstract] Cocks, B. 

Phrase: "89,"

Phrase: "9910-9914"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cocks,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.360: G., Vairo, G., Bodrug, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vairo,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bodrug,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.361: E., and Hamilton, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Hamilton,"

Phrase: "J."
Processing 00000000.tx.362: A. 

Phrase: "A."
Processing 00000000.tx.363: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.364: Biol. 

Phrase: "Biol."
Processing 00000000.tx.365: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.366: 267, 12307-12310[Abstract/Free FullText] Fukumoto, S., Nishizawa, Y., Hosoi, M., Koyama, H., Yamakawa, K., Ohno, S., and Morii, H. 

Phrase: "267,"

Phrase: "12307-12310"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fukumoto,"

Phrase: "S."

Phrase: ","

Phrase: "Nishizawa,"

Phrase: "Y.,"

Phrase: "Hosoi,"

Phrase: "M."

Phrase: ","

Phrase: "Koyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamakawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ohno,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Morii,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.367: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.368: Biol. 

Phrase: "Biol."
Processing 00000000.tx.369: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.370: 272, 13816-13822[Abstract/Free FullText] Pazin, M. 

Phrase: "272,"

Phrase: "13816-13822"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pazin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: J., and Williams, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Williams,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.372: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.373: (1992) Trends Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.374: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.375: 17, 374-378[CrossRef][Medline] [OrderarticleviaInfotrieve] Autrio, I., Jaakkola, O., Solakivi, T., and Nikkari, T. 

Phrase: "17,"

Phrase: "374-378"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Autrio,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jaakkola,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Solakivi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Nikkari,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.376: (1990) FEBS Lett. 

Phrase: "(1990"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.377: 277, 247-249[CrossRef][Medline] [OrderarticleviaInfotrieve] Chatterjee, S. 

Phrase: "277,"

Phrase: "247-249"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chatterjee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.379: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.380: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.381: 111, 143-147[Medline] [OrderarticleviaInfotrieve] Giraldo, A. 

Phrase: "111,"

Phrase: "143-147"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Giraldo,"

Phrase: "A."
Processing 00000000.tx.382: A., Esposo, O. 

Phrase: "A.,"

Phrase: "Esposo,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.383: M., and Meis, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Meis,"

Phrase: "J."
Processing 00000000.tx.384: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: (1985) Arch. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.386: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.387: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.388: Med. 

Phrase: "Med."
Processing 00000000.tx.389: 109, 173-175[Medline] [OrderarticleviaInfotrieve] Austin, G. 

Phrase: "109,"

Phrase: "173-175"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.390: E., Ratliff, M. 

Phrase: "E.,"

Phrase: "Ratliff,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.391: B., Hollman, J., Tabei, S., and Phillips, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hollman,"

Phrase: "J.,"

Phrase: "Tabei,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Phillips,"

Phrase: "D."
Processing 00000000.tx.392: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.393: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.394: Am. 

Phrase: "Am."
Processing 00000000.tx.395: Coll. 

Phrase: "Coll."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272373:COLL [Intellectual Product]
Processing 00000000.tx.396: Cardiol. 

Phrase: "Cardiol."
Processing 00000000.tx.397: 6, 369-375[Medline] [OrderarticleviaInfotrieve] Grotendorst, G. 

Phrase: "6,"

Phrase: "369-375"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grotendorst,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.398: R., Chang, T., Seppa, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chang,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Seppa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.399: E.J., Kleinman, H. 

Phrase: "E.J.,"

Phrase: "Kleinman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.400: K., and Martin, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.401: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.402: (1982) J. 

Phrase: "(1982"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.403: Cell Physiol. 

Phrase: "Cell Physiol."
Processing 00000000.tx.404: 113, 261-266[Medline] [OrderarticleviaInfotrieve] Jawien, A., Bowen-Pope, D. 

Phrase: "113,"

Phrase: "261-266"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jawien,"

Phrase: "A.,"

Phrase: "Bowen-Pope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0044577:POPE [Lipid]

Phrase: "D."
Processing 00000000.tx.405: F., Lindner, V., Schwartz, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lindner,"

Phrase: "V.,"

Phrase: "Schwartz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.406: M., and Clowes, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Clowes,"

Phrase: "A."
Processing 00000000.tx.407: W. 

Phrase: "W."
Processing 00000000.tx.408: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.409: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.410: Invest. 

Phrase: "Invest."
Processing 00000000.tx.411: 89, 507-511[Medline] [OrderarticleviaInfotrieve] Jackson, C. 

Phrase: "89,"

Phrase: "507-511"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jackson,"

Phrase: "C."
Processing 00000000.tx.412: L., Raines, E., Ross, R., and Reidy, M. 

Phrase: "L., Raines,"

Phrase: "E.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Reidy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.413: A. 

Phrase: "A."
Processing 00000000.tx.414: (1993) Arterioscler. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.415: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.416: 13, 1218-1226[Abstract] Claesson-Welsh, L. 

Phrase: "13,"

Phrase: "1218-1226"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Claesson-Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043114:Welsh [Population Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.417: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.418: Biol. 

Phrase: "Biol."
Processing 00000000.tx.419: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.420: 269, 32023-32026[Free FullText] Graves, L. 

Phrase: "269,"

Phrase: "32023-32026"

Phrase: "[Free FullText"

Phrase: "] Graves,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.421: M., Bornfeldt, K. 

Phrase: "M."

Phrase: ","

Phrase: "Bornfeldt,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: E., Sidhu, J. 

Phrase: "E.,"

Phrase: "Sidhu,"

Phrase: "J."
Processing 00000000.tx.423: S., Argast, G. 

Phrase: "S."

Phrase: ","

Phrase: "Argast,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.424: M., Raines, E. 

Phrase: "M."

Phrase: ","

Phrase: "Raines,"

Phrase: "E."
Processing 00000000.tx.425: W., Ross, R., Leslie, C. 

Phrase: "W., Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0331968:Ross [Health Care Related Organization]
   861   C2699100:Ross [Bird]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Leslie,"

Phrase: "C."
Processing 00000000.tx.426: C., and Krebs, E. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Krebs,"

Phrase: "E."
Processing 00000000.tx.427: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.428: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.429: Biol. 

Phrase: "Biol."
Processing 00000000.tx.430: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.431: 271, 505-511[Abstract/Free FullText] Seth, A., Gonzalez, A., Gupta, S., Raden, D. 

Phrase: "271,"

Phrase: "505-511"

Phrase: "[Abstract/Free FullText"

Phrase: "] Seth,"

Phrase: "A.,"

Phrase: "Gonzalez,"

Phrase: "A.,"

Phrase: "Gupta,"

Phrase: "S."

Phrase: ","

Phrase: "Raden,"

Phrase: "D."
Processing 00000000.tx.432: L., and Davis, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.433: J. 

Phrase: "J."
Processing 00000000.tx.434: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.435: Biol. 

Phrase: "Biol."
Processing 00000000.tx.436: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.437: 267, 24796-24804[Abstract/Free FullText] Chen, R. 

Phrase: "267,"

Phrase: "24796-24804"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.438: H., Sarnecki, C., and Blenis, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sarnecki,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Blenis,"

Phrase: "J."
Processing 00000000.tx.439: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.440: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.441: Biol. 

Phrase: "Biol."
Processing 00000000.tx.442: 12, 915-927[Abstract] Lavoie, J. 

Phrase: "12,"

Phrase: "915-927"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lavoie,"

Phrase: "J."
Processing 00000000.tx.443: N., L'Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J. 

Phrase: "N., L'Allemain,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brunet,"

Phrase: "A.,"

Phrase: "Muller,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Pouyssegur,"

Phrase: "J."
Processing 00000000.tx.444: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.445: Biol. 

Phrase: "Biol."
Processing 00000000.tx.446: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.447: 271, 20608-20616[Abstract/Free FullText] Abieu, A., Lorca, T., Labbe, J. 

Phrase: "271,"

Phrase: "20608-20616"

Phrase: "[Abstract/Free FullText"

Phrase: "] Abieu,"

Phrase: "A.,"

Phrase: "Lorca,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Labbe,"

Phrase: "J."
Processing 00000000.tx.448: C., Morin, N., Keyse, S., and Doree, M. 

Phrase: "C., Morin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0066801:morin [Organic Chemical,Pharmacologic Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Keyse,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Doree,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.449: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.450: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.451: 109, 239-246[Abstract/Free FullText] Majack, R. 

Phrase: "109,"

Phrase: "239-246"

Phrase: "[Abstract/Free FullText"

Phrase: "] Majack,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.452: A., Castle, C. 

Phrase: "A.,"

Phrase: "Castle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557597:Castle [Manufactured Object]

Phrase: "C."
Processing 00000000.tx.453: K., Goodman, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Goodman,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.454: V., Weisgraber, K. 

Phrase: "V., Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.455: H., Mahley, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.456: W., Shooter, E. 

Phrase: "W., Shooter,"

Phrase: "E."
Processing 00000000.tx.457: M., and Gebicke-Haerter, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gebicke-Haerter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.458: J. 

Phrase: "J."
Processing 00000000.tx.459: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.460: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.461: 107, 1207-1213[Abstract] Kruth, H. 

Phrase: "107,"

Phrase: "1207-1213"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kruth,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.462: S., Skarlatos, S. 

Phrase: "S."

Phrase: ","

Phrase: "Skarlatos,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.463: I., Gaynor, P. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gaynor,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.464: M., and Gamble, W. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gamble,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016995:gamble [Individual Behavior]

Phrase: "W."
Processing 00000000.tx.465: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.466: Biol. 

Phrase: "Biol."
Processing 00000000.tx.467: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.468: 269, 24511-24518[Abstract/Free FullText] Mazzone, T., and Reardon, C. 

Phrase: "269,"

Phrase: "24511-24518"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mazzone,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Reardon,"

Phrase: "C."
Processing 00000000.tx.469: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.470: Lipid Res. 

Phrase: "Lipid Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.471: 35, 1345-1353[Abstract] Miyata, M., and Smith, J. 

Phrase: "35,"

Phrase: "1345-1353"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Miyata,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.472: D. 

Phrase: "D."
Processing 00000000.tx.473: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.474: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.475: 14, 55-61[Medline] [OrderarticleviaInfotrieve] Riddell, D. 

Phrase: "14,"

Phrase: "55-61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Riddell,"

Phrase: "D."
Processing 00000000.tx.476: R., Graham, A., and Owen, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Graham,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Owen,"

Phrase: "J."
Processing 00000000.tx.477: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.478: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.479: Biol. 

Phrase: "Biol."
Processing 00000000.tx.480: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.481: 272, 89-95[Abstract/Free FullText] De Geest, B., Zhao, Z., Collen, D., and Holvoet, P. 

Phrase: "272,"

Phrase: "89-95"

Phrase: "[Abstract/Free FullText"

Phrase: "] De Geest,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zhao,"

Phrase: "Z.,"

Phrase: "Collen,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Holvoet,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.482: (1997) Circulation 96, 4349-4356[Abstract/Free FullText] Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J., and Yamamoto, T. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Circulation 96,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: "4349-4356"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takahashi,"

Phrase: "S."

Phrase: ","

Phrase: "Kawarabayasi,"

Phrase: "Y.,"

Phrase: "Nakai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sakai,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.483: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.484: Natl. 

Phrase: "Natl."
Processing 00000000.tx.485: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.486: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.487: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.488: 89, 9252-9256[Abstract] Russell, P. 

Phrase: "89,"

Phrase: "9252-9256"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.489: S., Chase, C. 

Phrase: "S."

Phrase: ","

Phrase: "Chase,"

Phrase: "C."
Processing 00000000.tx.490: M., and Colvin, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Colvin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.491: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.492: (1996) Am. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.493: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.494: 149, 91-99[Abstract] Reyland, M. 

Phrase: "149,"

Phrase: "91-99"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Reyland,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.495: E., Gwynne, J. 

Phrase: "E.,"

Phrase: "Gwynne,"

Phrase: "J."
Processing 00000000.tx.496: T., Forgez, P., Prack, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Forgez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Prack,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.497: M., and Williams, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Williams,"

Phrase: "D."
Processing 00000000.tx.498: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.499: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.500: Natl. 

Phrase: "Natl."
Processing 00000000.tx.501: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.502: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.503: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.504: 88, 2375-2379[Abstract] Dyer, C. 

Phrase: "88,"

Phrase: "2375-2379"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dyer,"

Phrase: "C."
Processing 00000000.tx.505: A., and Curtiss, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Curtiss,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.506: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.507: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.510: 263, 10965-10973[Abstract/Free FullText] Reyland, M. 

Phrase: "263,"

Phrase: "10965-10973"

Phrase: "[Abstract/Free FullText"

Phrase: "] Reyland,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.511: E., and Williams, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Williams,"

Phrase: "D."
Processing 00000000.tx.512: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.513: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.514: Biol. 

Phrase: "Biol."
Processing 00000000.tx.515: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.516: 266, 21099-21104[Abstract/Free FullText] Strittmatter, W. 

Phrase: "266,"

Phrase: "21099-21104"

Phrase: "[Abstract/Free FullText"

Phrase: "] Strittmatter,"

Phrase: "W."
Processing 00000000.tx.517: J., Saunders, A. 

Phrase: "J.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.518: M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. 

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Enghild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.519: S., and Roses, A. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.520: D. 

Phrase: "D."
Processing 00000000.tx.521: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.522: Natl. 

Phrase: "Natl."
Processing 00000000.tx.523: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.524: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.525: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.526: 90, 1977-1981[Abstract] Strittmatter, W. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1977-1981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Strittmatter,"

Phrase: "W."
Processing 00000000.tx.527: J., Saunders, A. 

Phrase: "J.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.528: M., Goedert, M., Weisgraber, K. 

Phrase: "M."

Phrase: ","

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.529: H., Dong, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dong,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.530: M., Jakes, R., Huang, D. 

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Huang,"

Phrase: "D."
Processing 00000000.tx.531: Y., Pericak-Vance, M., Schmechel, D., and Rose, A. 

Phrase: "Y.,"

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.532: D. 

Phrase: "D."
Processing 00000000.tx.533: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.534: Natl. 

Phrase: "Natl."
Processing 00000000.tx.535: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.536: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.537: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.538: 91, 11183-11186[Abstract/Free FullText] Nathan, B. 

Phrase: "91,"

Phrase: "11183-11186"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nathan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.539: P., Bellosta, S., Sanan, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Sanan,"

Phrase: "D."
Processing 00000000.tx.540: A., Weisgraber, K. 

Phrase: "A.,"

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.541: H., Mahley, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.542: W., and Pitas, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Pitas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.543: E. 

Phrase: "E."
Processing 00000000.tx.544: (1994) Science 264, 850-852[Medline] [OrderarticleviaInfotrieve] LaFerla, F. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "850-852"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] LaFerla,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.545: M., Troncoso, J. 

Phrase: "M."

Phrase: ","

Phrase: "Troncoso,"

Phrase: "J."
Processing 00000000.tx.546: C., Strickland, D. 

Phrase: "C., Strickland,"

Phrase: "D."
Processing 00000000.tx.547: K., Kawas, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kawas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521083:Kawas [Plant]

Phrase: "C."
Processing 00000000.tx.548: H., and Jay, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Jay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326402:Jay [Bird]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.549: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.550: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.551: Invest. 

Phrase: "Invest."
Processing 00000000.tx.552: 100, 310-320[Abstract/Free FullText] Marques, M. 

Phrase: "100,"

Phrase: "310-320"

Phrase: "[Abstract/Free FullText"

Phrase: "] Marques,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.553: A., Tolar, M., and Crutcher, K. 

Phrase: "A.,"

Phrase: "Tolar,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Crutcher,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.554: A. 

Phrase: "A."
Processing 00000000.tx.555: (1997) Alzheimer's Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alzheimer's Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.556: 3, 1-6 Hui, D. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "1-6 Hui,"

Phrase: "D."
Processing 00000000.tx.557: Y., Berebitsky, G. 

Phrase: "Y.,"

Phrase: "Berebitsky,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.558: L., and Harmony, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699798:harmony [Social Behavior]
  1000   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.559: A.K. 

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.560: (1979) J. 

Phrase: "(1979"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.561: Biol. 

Phrase: "Biol."
Processing 00000000.tx.562: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.563: 254, 4666-4673[Medline] [OrderarticleviaInfotrieve] Hui, D. 

Phrase: "254,"

Phrase: "4666-4673"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hui,"

Phrase: "D."
Processing 00000000.tx.564: Y., and Harmony, J. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699798:harmony [Social Behavior]
  1000   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.565: A.K. 

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.566: (1980) Biochem. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.567: J. 

Phrase: "J."
Processing 00000000.tx.568: 192, 91-98[Medline] [OrderarticleviaInfotrieve] Mistry, M. 

Phrase: "192,"

Phrase: "91-98"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mistry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.569: J., Clay, M. 

Phrase: "J.,"

Phrase: "Clay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055863:clay [Inorganic Chemical]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.570: A., Kelly, M. 

Phrase: "A.,"

Phrase: "Kelly,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.571: E., Steiner, M. 

Phrase: "E.,"

Phrase: "Steiner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.572: A., and Harmony, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699798:harmony [Social Behavior]
  1000   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.573: A.K. 

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.574: (1995) Cellular Immunology 160, 14-23[CrossRef][Medline] [OrderarticleviaInfotrieve] Vitek, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cellular Immunology 160,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1516368:Cellular Immunology [Biomedical Occupation or Discipline]
   827   C0007634:Cellular [Cell]
   827   C0152036:Immunology [Biomedical Occupation or Discipline]
   827   C0178539:Cellular [Functional Concept]
   827   C1522005:immunology [Qualitative Concept]
   755 E C0205470:Immunological [Functional Concept]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "14-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vitek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553145:Vitek [Laboratory Procedure]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.575: P., Snell, J., Dawson, H., and Colton, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Snell,"

Phrase: "J.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Colton,"

Phrase: "C."
Processing 00000000.tx.576: A. 

Phrase: "A."
Processing 00000000.tx.577: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.578: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.579: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.580: Commun. 

Phrase: "Commun."
Processing 00000000.tx.581: 240, 391-394[CrossRef][Medline] [OrderarticleviaInfotrieve] Garg, U. 

Phrase: "240,"

Phrase: "391-394"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Garg,"

Phrase: "U."
Processing 00000000.tx.582: C., and Hassid, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Hassid,"

Phrase: "A."
Processing 00000000.tx.583: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.584: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.585: Invest. 

Phrase: "Invest."
Processing 00000000.tx.586: 83, 1774-1777[Medline] [OrderarticleviaInfotrieve] Yamamoto, T., and Bujo, H. 

Phrase: "83,"

Phrase: "1774-1777"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Bujo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.587: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.588: Opin. 

Phrase: "Opin."
Processing 00000000.tx.589: Lipidol. 

Phrase: "Lipidol."
Processing 00000000.tx.590: 7, 298-302[Medline] [OrderarticleviaInfotrieve] Schneider, W. 

Phrase: "7,"

Phrase: "298-302"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schneider,"

Phrase: "W."
Processing 00000000.tx.591: J., Nimpf, J., and Bujo, H. 

Phrase: "J.,"

Phrase: "Nimpf,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Bujo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.592: (1997) Curr. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.593: Opin. 

Phrase: "Opin."
Processing 00000000.tx.594: Lipidol. 

Phrase: "Lipidol."
Processing 00000000.tx.595: 8, 315-319[Medline] [OrderarticleviaInfotrieve] Misra, U. 

Phrase: "8,"

Phrase: "315-319"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Misra,"

Phrase: "U."
Processing 00000000.tx.596: K., Chu, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chu,"

Phrase: "C."
Processing 00000000.tx.597: T.C., Gawdi, G., and Pizzo, S. 

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Gawdi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Pizzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.598: V. 

Phrase: "V."
Processing 00000000.tx.599: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.600: Biol. 

Phrase: "Biol."
Processing 00000000.tx.601: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.602: 269, 18303-18306[Abstract/Free FullText] Okada, S. 

Phrase: "269,"

Phrase: "18303-18306"

Phrase: "[Abstract/Free FullText"

Phrase: "] Okada,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.603: S., Grobmyer, S. 

Phrase: "S."

Phrase: ","

Phrase: "Grobmyer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.604: R., and Barnathan, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Barnathan,"

Phrase: "E."
Processing 00000000.tx.605: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.606: (1996) Arterioscler. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.607: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.608: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.609: Biol. 

Phrase: "Biol."
Processing 00000000.tx.610: 16, 1269-1276[Abstract/Free FullText] Copyright  1998 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "16,"

Phrase: "1269-1276"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  1998 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

